SynGap Missense Server

Table of SynGAP1 Isoform α2 (UniProt Q96PV0-1) Missense Variants.

c.dna Variant SGM Consensus Domain ClinVar gnomAD ESM1b AlphaMissense REVEL FoldX Rosetta Foldetta PremPS PROVEAN PolyPhen-2 HumDiv PolyPhen-2 HumVar FATHMM SIFT PAM Physical SASA Normalized B-factor backbone Normalized B-factor sidechain SynGAP Structural Annotation DOI
Clinical Status Review Subm. ID Allele count Allele freq. LLR score Prediction Pathogenicity Class Optimized Score Prediction Average ΔΔG Prediction StdDev ΔΔG Prediction ΔΔG Prediction ΔΔG Prediction Score Prediction pph2_prob Prediction pph2_prob Prediction Nervous System Score Prediction Prediction Status Conservation Sequences PAM250 PAM120 Hydropathy Δ MW Δ Average Δ Δ StdDev Δ StdDev Secondary Tertiary bonds Inside out GAP-Ras interface At membrane No effect MD Alert Verdict Description
c.4021G>AA1341TLikely BenignConflicting 36-33451895-G-A453.44e-5-3.224Likely Benign0.081Likely BenignLikely Benign0.099Likely Benign-0.58Neutral0.000Benign0.000Benign4.09Benign0.03Affected3.77510-2.530.03
c.4021G>TA1341SLikely BenignUncertain 16-33451895-G-T-2.867Likely Benign0.078Likely BenignLikely Benign0.099Likely Benign0.80Neutral0.000Benign0.001Benign4.40Benign1.00Tolerated3.77511-2.616.00
c.404G>AR135QUncertain 16-33432701-G-A53.84e-6-8.011Likely Pathogenic0.853Likely PathogenicAmbiguous0.087Likely Benign-1.94Neutral0.327Benign0.100Benign3.76Benign0.02Affected3.615111.0-28.06
c.406C>TR136WLikely PathogenicUncertain 2-10.453Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.237Likely Benign-4.71Deleterious0.965Probably Damaging0.416Benign3.45Benign0.00Affected3.6152-33.630.03
c.407G>AR136QBenign 16-33432704-G-A139.17e-6-11.146Likely Pathogenic0.950Likely PathogenicAmbiguous0.190Likely Benign-2.26Neutral0.957Probably Damaging0.342Benign3.52Benign0.01Affected3.615111.0-28.06
c.407G>CR136PLikely PathogenicUncertain 1-11.952Likely Pathogenic0.981Likely PathogenicLikely Pathogenic0.277Likely Benign-3.72Deleterious0.910Possibly Damaging0.578Possibly Damaging3.47Benign0.00Affected3.6150-22.9-59.07
c.416G>AS139NLikely BenignUncertain 16-33432713-G-A32.22e-6-4.584Likely Benign0.688Likely PathogenicLikely Benign0.109Likely Benign-0.75Neutral0.149Benign0.047Benign4.14Benign0.24Tolerated3.61511-2.727.03
c.431C>TT144MLikely PathogenicUncertain 26-33432728-C-T21.30e-6-11.228Likely Pathogenic0.922Likely PathogenicAmbiguous0.118Likely Benign-3.16Deleterious0.913Possibly Damaging0.333Benign3.73Benign0.00Affected3.615-1-12.630.09
c.43G>AA15TLikely BenignUncertain 16-33420307-G-A42.60e-6-3.720Likely Benign0.125Likely BenignLikely Benign0.086Likely Benign-0.08Neutral0.602Possibly Damaging0.017Benign4.16Benign0.00Affected4.32110-2.530.03
c.43G>CA15PLikely BenignUncertain 1-3.436Likely Benign0.097Likely BenignLikely Benign0.146Likely Benign-0.23Neutral0.880Possibly Damaging0.123Benign4.09Benign0.00Affected1-1-3.426.04
c.44C>TA15VLikely BenignUncertain 16-33420308-C-T16.49e-7-3.560Likely Benign0.161Likely BenignLikely Benign0.105Likely Benign0.20Neutral0.602Possibly Damaging0.015Benign4.19Benign0.00Affected4.321002.428.05
c.451G>CD151HLikely PathogenicUncertain 16-33432748-G-C21.26e-6-11.747Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.335Likely Benign-3.90Deleterious0.999Probably Damaging0.995Probably Damaging3.86Benign0.00Affected3.615-110.322.05
c.453C>AD151ELikely BenignUncertain 1-5.662Likely Benign0.886Likely PathogenicAmbiguous0.142Likely Benign-2.02Neutral0.984Probably Damaging0.967Probably Damaging3.99Benign0.11Tolerated3.615320.014.03
c.455G>AR152QUncertain 16-33432752-G-A53.14e-6-10.336Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.181Likely Benign-2.34Neutral0.997Probably Damaging0.968Probably Damaging3.89Benign0.00Affected3.615111.0-28.06
c.458C>AT153NLikely BenignConflicting 3-0.739Likely Benign0.226Likely BenignLikely Benign0.161Likely Benign0.88Neutral0.888Possibly Damaging0.537Possibly Damaging4.23Benign0.81Tolerated3.61500-2.813.00
c.467T>GF156CLikely PathogenicUncertain 1-13.658Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.297Likely Benign-3.54Deleterious0.999Probably Damaging0.990Probably Damaging3.92Benign0.00Affected-4-2-0.3-44.04
c.470G>AR157HUncertain 16-33432767-G-A16.20e-7-10.235Likely Pathogenic0.604Likely PathogenicLikely Benign0.254Likely Benign-2.23Neutral0.999Probably Damaging0.987Probably Damaging3.80Benign0.00Affected3.744201.3-19.05
c.484C>GR162GLikely BenignUncertain 1-6.985Likely Benign0.664Likely PathogenicLikely Benign0.190Likely Benign-0.73Neutral0.487Possibly Damaging0.272Benign4.09Benign0.78Tolerated3.744-2-34.1-99.14
c.484C>TR162CPathogenic 2-8.157Likely Pathogenic0.787Likely PathogenicAmbiguous0.150Likely Benign-2.05Neutral0.988Probably Damaging0.513Possibly Damaging4.00Benign0.11Tolerated3.744-4-37.0-53.05
c.485G>AR162HUncertain 16-33432782-G-A21.24e-6-9.730Likely Pathogenic0.480AmbiguousLikely Benign0.167Likely Benign-1.13Neutral0.957Probably Damaging0.513Possibly Damaging4.03Benign0.12Tolerated3.744201.3-19.05
c.48G>AM16ILikely BenignUncertain 16-33420312-G-A16.49e-7-2.198Likely Benign0.722Likely PathogenicLikely Benign0.057Likely Benign-0.15Neutral0.000Benign0.000Benign4.28Benign0.00Affected4.321212.6-18.03
c.491G>AR164QUncertain 16-33432788-G-A21.24e-6-11.208Likely Pathogenic0.600Likely PathogenicLikely Benign0.184Likely Benign-1.86Neutral0.957Probably Damaging0.342Benign3.82Benign0.00Affected3.744111.0-28.06
c.502C>TH168YLikely BenignBenign 1-8.914Likely Pathogenic0.264Likely BenignLikely Benign0.065Likely Benign-1.53Neutral0.192Benign0.062Benign4.18Benign0.01Affected4.323021.926.03
c.505G>AD169NUncertain 1-10.713Likely Pathogenic0.761Likely PathogenicLikely Benign0.110Likely Benign-2.04Neutral0.079Benign0.052Benign4.07Benign0.01Affected3.744210.0-0.98
c.508C>TR170WLikely PathogenicUncertain 2-11.660Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.241Likely Benign-4.28Deleterious0.999Probably Damaging0.849Possibly Damaging3.84Benign0.00Affected3.7442-33.630.03
c.509G>AR170QPathogenic/Likely path. 6-9.021Likely Pathogenic0.798Likely PathogenicAmbiguous0.221Likely Benign-2.31Neutral0.947Possibly Damaging0.342Benign3.91Benign0.00Affected3.744111.0-28.0610.1016/j.ajhg.2020.11.011
c.50C>TS17FLikely BenignUncertain 16-33420314-C-T106.49e-6-3.888Likely Benign0.637Likely PathogenicLikely Benign0.048Likely Benign-0.99Neutral0.486Possibly Damaging0.032Benign3.99Benign0.00Affected4.321-2-33.660.10
c.514C>TR172WLikely PathogenicUncertain 26-33435156-C-T95.58e-6-10.258Likely Pathogenic0.878Likely PathogenicAmbiguous0.228Likely Benign-3.61Deleterious0.997Probably Damaging0.803Possibly Damaging3.95Benign0.00Affected3.6152-33.630.03
c.515G>AR172QUncertain 16-33435157-G-A31.86e-6-7.245In-Between0.465AmbiguousLikely Benign0.135Likely Benign-1.72Neutral0.804Possibly Damaging0.091Benign4.04Benign0.04Affected3.615111.0-28.06
c.526A>CS176RLikely BenignUncertain 1-6.492Likely Benign0.987Likely PathogenicLikely Pathogenic0.247Likely Benign0.94Neutral0.718Possibly Damaging0.168Benign4.16Benign0.87Tolerated0-1-3.769.11
c.526A>GS176GUncertain 16-33435168-A-G16.20e-7-7.541In-Between0.360AmbiguousLikely Benign0.066Likely Benign-1.08Neutral0.131Benign0.039Benign4.08Benign0.22Tolerated3.546010.4-30.03
c.53A>GY18CLikely BenignUncertain 16-33420317-A-G442.88e-5-2.658Likely Benign0.251Likely BenignLikely Benign0.102Likely Benign-0.56Neutral0.872Possibly Damaging0.206Benign4.04Benign0.00Affected4.3210-23.8-60.04
c.558G>CL186FLikely PathogenicUncertain 1-11.861Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.132Likely Benign-3.03Deleterious0.009Benign0.012Benign3.50Benign0.00Affected20-1.034.02
c.583G>CA195PLikely PathogenicLikely Pathogenic 1-9.715Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.152Likely Benign-3.03Deleterious0.997Probably Damaging0.916Probably Damaging4.00Benign0.04Affected3.5461-1-3.426.04
c.59C>GP20RLikely BenignUncertain 1-3.548Likely Benign0.434AmbiguousLikely Benign0.146Likely Benign-0.15Neutral0.972Probably Damaging0.804Possibly Damaging4.33Benign0.00Affected4.3210-2-2.959.07
c.59C>TP20LLikely BenignUncertain 3-3.289Likely Benign0.464AmbiguousLikely Benign0.100Likely Benign-0.44Neutral0.909Possibly Damaging0.713Possibly Damaging4.27Benign0.00Affected4.321-3-35.416.04
c.5G>AS2NLikely BenignUncertain 26-33420269-G-A31.96e-6-4.104Likely Benign0.207Likely BenignLikely Benign0.092Likely Benign-0.36Neutral0.000Benign0.000Benign4.06Benign0.00Affected4.32111-2.727.03
c.68A>GD23GLikely BenignUncertain 1-2.622Likely Benign0.684Likely PathogenicLikely Benign0.100Likely Benign-2.45Neutral0.805Possibly Damaging0.539Possibly Damaging3.50Benign0.00Affected1-13.1-58.04
c.70G>AV24ILikely BenignUncertain 16-33423479-G-A95.58e-6-3.701Likely Benign0.137Likely BenignLikely Benign0.069Likely Benign-0.25Neutral0.043Benign0.031Benign3.96Benign0.00Affected4.321340.314.03
c.73C>TR25WLikely BenignUncertain 26-33423482-C-T63.72e-6-5.133Likely Benign0.549AmbiguousLikely Benign0.158Likely Benign-1.60Neutral0.994Probably Damaging0.919Probably Damaging3.92Benign0.00Affected4.321-323.630.03
c.74G>AR25QLikely BenignUncertain 16-33423483-G-A159.29e-6-4.126Likely Benign0.212Likely BenignLikely Benign0.038Likely Benign-0.70Neutral0.829Possibly Damaging0.614Possibly Damaging4.01Benign0.00Affected4.321111.0-28.06
c.76G>AG26RLikely BenignBenign 16-33423485-G-A31.86e-6-2.946Likely Benign0.678Likely PathogenicLikely Benign0.189Likely Benign-2.22Neutral0.994Probably Damaging0.990Probably Damaging3.87Benign0.00Affected4.321-3-2-4.199.14
c.82T>CS28PLikely BenignUncertain 1-3.309Likely Benign0.051Likely BenignLikely Benign0.047Likely Benign1.37Neutral0.000Benign0.000Benign4.53Benign0.00Affected4.3211-1-0.810.04
c.86T>CM29TLikely BenignUncertain 1-2.167Likely Benign0.122Likely BenignLikely Benign0.199Likely Benign-0.37Neutral0.018Benign0.184Benign4.33Benign0.00Affected4.321-1-1-2.6-30.09
c.88C>TH30YLikely BenignUncertain 1-3.047Likely Benign0.115Likely BenignLikely Benign0.082Likely Benign-1.84Neutral0.273Benign0.478Possibly Damaging3.99Benign0.00Affected4.321021.926.03
c.92G>AR31QLikely BenignUncertain 16-33423501-G-A74.34e-6-4.434Likely Benign0.136Likely BenignLikely Benign0.051Likely Benign-0.92Neutral0.829Possibly Damaging0.614Possibly Damaging4.01Benign0.00Affected4.321111.0-28.06
c.819G>TE273D
(3D Viewer)
Likely BenignC2Benign 16-33437724-G-T21.24e-6-1.811Likely Benign0.058Likely BenignLikely Benign0.092Likely Benign0.26Likely Benign0.1-0.48Likely Benign-0.11Likely Benign-0.63Ambiguous1.99Neutral0.004Benign0.010Benign2.00Pathogenic1.00Tolerated3.3818320.0-14.03223.122.10.20.00.00.1XPotentially BenignThe negatively charged residue Glu273, located in a β hairpin loop (res. Glu273-Lys278) that connects two anti-parallel β sheet strands, is replaced with another negatively charged residue, aspartate. Because the C2 domain loop faces the membrane surface, the potentially crucial role of the carboxylate group of Glu273 or Asp273 on SynGAP-membrane association cannot be fully explored via solvent-only simulations.As a minor note, the neighboring residue Arg272, which stacks with the indole ring of the Trp362 side chain and directly faces RasGTPase, forms a salt bridge more often with Asp273 than with the non-mutated Glu273 in the simulations. Regardless, due to the similar physicochemical properties of the WT and variant residues at the membrane interface, the residue swap is likely to be well tolerated.
c.1663G>AV555I
(3D Viewer)
Likely BenignGAPUncertain 1-4.544Likely Benign0.084Likely BenignLikely Benign0.253Likely Benign-0.82Ambiguous0.0-0.41Likely Benign-0.62Ambiguous-0.55Ambiguous0.45Neutral0.002Benign0.002Benign-1.26Pathogenic1.00Tolerated430.314.03
c.1136C>TS379L
(3D Viewer)
Likely BenignC2Benign 16-33438041-C-T84.05e-5-5.641Likely Benign0.173Likely BenignLikely Benign0.469Likely Benign0.39Likely Benign0.23.38Destabilizing1.89Ambiguous-0.52Ambiguous-0.85Neutral0.015Benign0.002Benign3.83Benign0.04Affected4.3211-3-24.626.08251.9-48.10.61.10.00.5UncertainSer379 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus hydrophobic residues like leucine are rarely tolerated. Although no negative structural effects are observed in the variant simulations, Leu379 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effect on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1027G>AV343I
(3D Viewer)
Likely BenignC2Uncertain 26-33437932-G-A16.20e-7-6.020Likely Benign0.117Likely BenignLikely Benign0.020Likely Benign-0.27Likely Benign0.0-0.04Likely Benign-0.16Likely Benign-0.39Likely Benign-0.14Neutral0.159Benign0.084Benign1.98Pathogenic0.27Tolerated3.3725430.314.03240.2-26.9-0.20.2-0.20.2XPotentially BenignThe iso-propyl side chain of Val343, located in an anti-parallel β sheet strand (res. Gly341-Pro349), is packing against multiple hydrophobic residues of the C2 domain (e.g., Leu327, Leu274, Val365). In the variant simulations, the sec-butyl side chain of Ile343 is basically able to form the same interactions as valine due to its similar hydrophobic profile. The residue swap also does not seem to cause negative effects on the protein structure based on the simulations.
c.2101C>TP701S
(3D Viewer)
Likely BenignGAPUncertain 16-33441360-C-T31.86e-6-4.375Likely Benign0.221Likely BenignLikely Benign0.132Likely Benign1.33Ambiguous0.00.12Likely Benign0.73Ambiguous-0.36Likely Benign0.78Neutral0.044Benign0.025Benign3.48Benign1.00Tolerated3.4710-110.8-10.0410.1016/j.ajhg.2020.11.011
c.2186A>GN729S
(3D Viewer)
Likely BenignGAPUncertain 1-1.578Likely Benign0.066Likely BenignLikely Benign0.063Likely Benign0.14Likely Benign0.11.34Ambiguous0.74Ambiguous-0.36Likely Benign-0.42Neutral0.221Benign0.027Benign3.38Benign0.93Tolerated3.597112.7-27.03
c.1160G>TG387V
(3D Viewer)
Likely BenignC2Uncertain 16-33438065-G-T221.37e-5-6.199Likely Benign0.153Likely BenignLikely Benign0.390Likely Benign5.13Destabilizing1.86.44Destabilizing5.79Destabilizing-0.33Likely Benign-0.54Neutral0.069Benign0.077Benign1.32Pathogenic0.01Affected4.323-1-34.642.08207.7-68.4-0.70.8-0.50.1UncertainGly387 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364 and res. Ala399-Ile411). The Ω loop is assumed to directly interact with the membrane, and it is observed to move arbitrarily throughout the WT solvent simulations. This loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play significant roles in protein functions that require flexibility, and thus hydrophobic residues like valine are rarely tolerated. Although no negative structural effects are visualized in the variant’s simulations, Val387 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. Since the effects on the Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1142G>TG381V
(3D Viewer)
Likely BenignC2Uncertain 16-33438047-G-T21.25e-6-5.967Likely Benign0.146Likely BenignLikely Benign0.618Likely Pathogenic7.16Destabilizing1.04.10Destabilizing5.63Destabilizing-0.32Likely Benign-0.95Neutral0.386Benign0.157Benign1.32Pathogenic0.10Tolerated4.329-1-34.642.08214.6-68.80.30.7-0.50.3UncertainGly381 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus hydrophobic residues like valine are rarely tolerated. Although no negative structural effects are observed in the variant simulations, Val381 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effects on Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1811C>TS604L
(3D Viewer)
Likely PathogenicGAPUncertain 16-33440863-C-T63.72e-6-14.683Likely Pathogenic0.965Likely PathogenicLikely Pathogenic0.639Likely Pathogenic-0.94Ambiguous0.1-1.24Ambiguous-1.09Ambiguous-0.31Likely Benign-5.97Deleterious1.000Probably Damaging0.991Probably Damaging3.09Benign0.00Affected3.3735-3-24.626.08234.0-49.60.00.10.30.5XXPotentially PathogenicSer604 is located in a short turn between an α helix (res. Glu582-Met603) and a short α helical section (res. Ser606-Phe608). In the WT simulations, the hydroxyl side chain of Ser604 periodically hydrogen bonds with the backbone carbonyl groups of other α helix residues (e.g., Pro600, Met603). Serine weakens the α helix secondary structure, and thus, Ser604 along with Pro605 breaks the α helix, facilitating the turn in the WT structure.In contrast, in the variant simulations, Leu604 forms a few hydrophobic interactions (e.g., Leu607, Phe608). More importantly, the helix end is more stable than with Ser604 in the WT. The residue swap could have a more profound effect on the actual folding process, for example, by preventing the bending at the α helix end, than what the simulations suggest.Moreover, Ser604 directly hydrogen bonds with Ras residues Ser65 and Ala66 in the WT SynGAP-Ras complex. The hydrophobic leucine cannot maintain these interactions with Ras at the GAP-Ras interface. Thus, the effect of the residue swap on the complex formation with the GTPase cannot be fully explored in the solvent-only simulations.
c.1918A>TT640S
(3D Viewer)
Likely BenignGAPBenign 16-33441177-A-T16.20e-7-2.371Likely Benign0.062Likely BenignLikely Benign0.088Likely Benign-0.78Ambiguous0.10.43Likely Benign-0.18Likely Benign-0.30Likely Benign0.92Neutral0.000Benign0.001Benign3.60Benign0.33Tolerated3.373011-0.1-14.03
c.1198G>CV400L
(3D Viewer)
Likely BenignC2Benign 16-33438103-G-C221.36e-5-1.000Likely Benign0.137Likely BenignLikely Benign0.325Likely Benign-0.71Ambiguous0.20.39Likely Benign-0.16Likely Benign-0.29Likely Benign-0.60Neutral0.001Benign0.001Benign5.33Benign0.64Tolerated3.382721-0.414.03251.0-30.10.00.00.70.1XPotentially BenignThe iso-propyl side chain of Val400, located in an anti-parallel β sheet strand (res. Ala399-Ile411), hydrophobically packs against hydrophobic residues within the anti-parallel β sheet of the C2 domain (e.g., Ile268, Ala404, Leu325, Leu402). Val400 is swapped for another hydrophobic residue, leucine, whose branched hydrocarbon side chain is of a comparable size and thus packs favorably within the C2 domain. In short, the residue swap has no apparent negative effect on the structure based on the variant simulations.10.1016/j.ajhg.2020.11.011
c.1154C>TS385L
(3D Viewer)
Likely BenignC2Uncertain 26-33438059-C-T94.60e-5-6.018Likely Benign0.167Likely BenignLikely Benign0.304Likely Benign0.16Likely Benign0.10.08Likely Benign0.12Likely Benign-0.26Likely Benign-0.68Neutral0.829Possibly Damaging0.706Possibly Damaging4.63Benign0.01Affected4.323-3-24.626.08244.6-50.10.00.6-0.10.1UncertainSer385 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus hydrophobic residues like leucine are rarely tolerated. Although no negative structural effects are observed in the variant simulations, Leu385 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effects on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1964T>AL655Q
(3D Viewer)
Likely BenignGAPUncertain 1-5.278Likely Benign0.144Likely BenignLikely Benign0.139Likely Benign-0.01Likely Benign0.00.69Ambiguous0.34Likely Benign-0.15Likely Benign0.61Neutral0.955Possibly Damaging0.602Possibly Damaging3.59Benign0.65Tolerated3.3924-2-2-7.314.97229.9-8.60.00.00.40.0XPotentially BenignThe iso-butyl side chain of Leu655, located on the surface of an α helix (res. Ser641-Glu666), is not involved in any interactions in the WT simulations. In the variant simulations, the carboxamide side chain of Gln655 dynamically interacts with neighboring residues (e.g., Glu651, Glu656, Arg544) on the protein surface, with no negative structural effects.
c.1579G>TD527Y
(3D Viewer)
Likely PathogenicGAPUncertain 1-15.386Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.905Likely Pathogenic-0.77Ambiguous0.21.89Ambiguous0.56Ambiguous-0.14Likely Benign-8.79Deleterious1.000Probably Damaging0.999Probably Damaging-2.41Pathogenic0.00Affected3.3735-4-32.248.09270.9-45.70.10.1-0.10.0XPotentially PathogenicAsp527 is located on an α-α loop between the two α-helices (res. Gly502-Tyr518 and Ala533-Val560). In the WT simulations, the carboxylate group of the Asp527 side chain forms hydrogen bonds with the backbone atoms of loop residues (e.g., Ile529, Lys530) facing the membrane surface. In the variant simulations, Tyr527 is a bulkier residue that faces away from the loop and stacks with Phe646 in a nearby α-helix (res. Ser614-Ser668). Regardless, no negative structural effects are observed during the variant simulations. However, due to its location near the SynGAP-membrane interface, the effect of the residue swap cannot be fully addressed using the SynGAP solvent-only simulations.
c.1685C>TP562L
(3D Viewer)
Likely PathogenicGAPPathogenic/Likely path. 106-33440737-C-T-13.438Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.829Likely Pathogenic3.54Destabilizing0.80.17Likely Benign1.86Ambiguous-0.14Likely Benign-9.95Deleterious1.000Probably Damaging1.000Probably Damaging0.58Pathogenic0.00Affected3.3735-3-35.416.04228.8-68.5-0.10.00.10.2XPotentially PathogenicPro562 is located on an α-α loop between two α-helices (res. Ala533-Val560 and res. Arg563-Glu578). The cyclic pyrrolidine side chain of Pro562 hydrophobically packs with other residues in the inter-helix space, such as Leu565, Ile501, and Phe561. In the variant simulations, Leu562 packs more favorably with the nearby hydrophobic residues, and the backbone amide group of Leu562 (absent in proline) does not form any intra-protein hydrogen bonds. However, prolines are well-suited for unstructured regions like loops, and thus, Pro562 in the WT is necessary at the end of the helix to induce a tight turn during folding. Although no negative structural effects are observed during the simulations, the residue swap could potentially cause extensive damage to the protein structure during folding.10.1016/j.ajhg.2020.11.011
c.1172G>TG391V
(3D Viewer)
Likely BenignC2Likely Benign 16-33438077-G-T31.86e-6-6.642Likely Benign0.133Likely BenignLikely Benign0.595Likely Pathogenic4.23Destabilizing1.34.81Destabilizing4.52Destabilizing-0.11Likely Benign-0.98Neutral0.994Probably Damaging0.887Possibly Damaging1.32Pathogenic0.10Tolerated3.698-1-34.642.08228.6-69.00.00.8-0.50.3UncertainGly387 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364 and res. Ala399-Ile411). The Ω loop is assumed to directly interact with the membrane, and it is observed to move arbitrarily throughout the WT solvent simulations. This loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play significant roles in protein functions that require flexibility, and thus hydrophobic residues like valine are rarely tolerated. Although no negative structural effects are visualized in the variant’s simulations, Val391 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. Since the effects on the Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1040C>AT347N
(3D Viewer)
Likely BenignC2Uncertain 16-33437945-C-A95.58e-6-5.545Likely Benign0.165Likely BenignLikely Benign0.059Likely Benign0.41Likely Benign0.10.46Likely Benign0.44Likely Benign-0.06Likely Benign1.96Neutral0.001Benign0.001Benign1.67Pathogenic0.60Tolerated3.372500-2.813.00
c.1417G>AV473I
(3D Viewer)
GAPUncertain 16-33438449-G-A16.20e-7-7.481In-Between0.418AmbiguousLikely Benign0.203Likely Benign-0.12Likely Benign0.01.20Ambiguous0.54Ambiguous-0.06Likely Benign-0.91Neutral0.929Possibly Damaging0.917Probably Damaging3.74Benign0.18Tolerated3.3734340.314.03
c.1786C>TR596C
(3D Viewer)
Likely PathogenicGAPConflicting 26-33440838-C-T63.72e-6-10.805Likely Pathogenic0.972Likely PathogenicLikely Pathogenic0.633Likely Pathogenic2.94Destabilizing0.01.49Ambiguous2.22Destabilizing-0.03Likely Benign-7.96Deleterious1.000Probably Damaging1.000Probably Damaging2.41Pathogenic0.00Affected3.3735-4-37.0-53.05230.797.9-0.10.0-0.30.4XXPotentially PathogenicThe guanidinium group of Arg596, located in an α helix (res. Glu582-Met603), forms a salt bridge with the carboxylate group of Glu495 from another α helix (res. Leu489-Glu519). In the WT simulations, the side chain of Arg596 hydrogen bonds with the backbone carbonyl groups of Asn487, Glu486, Arg485, and Phe484. Additionally, Arg596 can hydrogen bond with the carboxamide group of the Asn487 side chain on an opposing loop that links two α helices (res. Ala461-Arg475, res. Leu489-Glu519).In the variant simulations, the thiol group of the Cys596 side chain is unable to form salt bridges or any of the hydrogen bonds that the Arg596 side chain can. Thus, the residue swap could affect the tertiary structure assembly more profoundly than observed in the simulations. Notably, Arg596 plays a key role in positioning the aforementioned loop, which is crucial for the placement of the “arginine finger” or the Arg485 side chain during RasGTPase activation.
c.862G>AD288N
(3D Viewer)
Likely PathogenicC2Uncertain 16-33437767-G-A21.24e-6-10.535Likely Pathogenic0.521AmbiguousLikely Benign0.321Likely Benign-0.39Likely Benign0.10.01Likely Benign-0.19Likely Benign-0.03Likely Benign-3.73Deleterious0.999Probably Damaging0.997Probably Damaging1.78Pathogenic0.05Affected3.3823120.0-0.98
c.1118G>AG373E
(3D Viewer)
C2Uncertain 1-7.281In-Between0.569Likely PathogenicLikely Benign0.420Likely Benign4.13Destabilizing3.20.52Ambiguous2.33Destabilizing-0.02Likely Benign-0.69Neutral0.001Benign0.000Benign3.90Benign0.01Affected0-2-3.172.06
c.1108G>AG370S
(3D Viewer)
Likely BenignC2Uncertain 16-33438013-G-A159.31e-6-3.533Likely Benign0.081Likely BenignLikely Benign0.282Likely Benign2.83Destabilizing2.01.05Ambiguous1.94Ambiguous-0.02Likely Benign0.47Neutral0.000Benign0.000Benign1.33Pathogenic0.77Tolerated3.421910-0.430.03196.6-49.60.92.2-0.10.4UncertainGly370 is located in the Gly-rich Ω loop (res. Pro364- Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because, the Ω loop is assumed to be directly interacting with the membrane, it is only seen to move arbitrarily throughout the WT solvent simulations. The Ω loop is potentially playing a crucial loop in the SynGAP-membrane complex association, stability and dynamics, regardless, this aspect cannot be addressed through the solvent simulations only. The Ω-loops are known to have a major role in protein functions that requires flexibility and thus, they are rich in glycines, prolines and to a lesser extent, hydrophilic residues to ensure maximum flexibility. Thus, Ser370 in the variant is potentially tolerated in the Ω loop. However, since the effect on the Gly-rich Ω loop dynamics can only be well-studied through the SynGAP-membrane complex, no definite conclusions can be withdrawn.
c.1121C>AS374Y
(3D Viewer)
C2Uncertain 1-7.774In-Between0.344AmbiguousLikely Benign0.310Likely Benign0.71Ambiguous1.20.66Ambiguous0.69Ambiguous-0.02Likely Benign-1.18Neutral0.875Possibly Damaging0.271Benign5.41Benign0.01Affected4.3213-3-2-0.576.10237.3-76.90.50.40.50.3UncertainSer374 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus, large and relatively hydrophobic residues like tyrosine are rarely tolerated. Additionally, the hydroxyl group of Tyr374 frequently forms various hydrogen bonds with other loop residues in the variant simulations. Although no negative structural effects are observed in the variant simulations, Tyr374 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effect on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.2113A>CK705Q
(3D Viewer)
Likely BenignGAPUncertain 16-33441372-A-C16.20e-7-5.787Likely Benign0.436AmbiguousLikely Benign0.142Likely Benign-0.10Likely Benign0.00.33Likely Benign0.12Likely Benign-0.02Likely Benign-0.24Neutral0.997Probably Damaging0.969Probably Damaging3.42Benign0.78Tolerated3.4710110.4-0.04
c.1787G>TR596L
(3D Viewer)
Likely PathogenicGAPUncertain 1-13.197Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.756Likely Pathogenic1.51Ambiguous0.3-0.58Ambiguous0.47Likely Benign-0.02Likely Benign-6.97Deleterious1.000Probably Damaging1.000Probably Damaging2.45Pathogenic0.00Affected3.3735-3-28.3-43.03234.263.4-0.10.0-0.50.6XXPotentially PathogenicThe guanidinium group of Arg596, located in an α helix (res. Glu582-Met603), forms a salt bridge with the carboxylate group of Glu495 from another α helix (res. Leu489-Glu519). In the WT simulations, the side chain of Arg596 hydrogen bonds with the backbone carbonyl groups of Asn487, Glu486, Arg485, and Phe484. Additionally, Arg596 can hydrogen bond with the carboxamide group of the Asn487 side chain on an opposing loop that links two α helices (res. Ala461-Arg475, res. Leu489-Glu519).However, in the variant simulations, the branched hydrocarbon side chain of Leu596 cannot form any of the hydrogen bonds or salt bridges maintained by the considerably bulkier and positively charged Arg596 side chain. Instead, Leu596 packs hydrophobically with the phenyl ring of Phe484 in the linker loop or residues from the opposing helix (e.g., Ile494, Thr491).Thus, the residue swap could affect the tertiary structure assembly more profoundly than observed in the simulations. Notably, Arg596 plays a key role in positioning the aforementioned loop, which is crucial for the placement of the “arginine finger” or the Arg485 side chain during RasGTPase activation.10.1016/j.ajhg.2020.11.011
c.866T>CM289TLikely BenignC2Uncertain1-4.668Likely Benign0.238Likely BenignLikely Benign0.222Likely Benign0.73Ambiguous0.10.17Likely Benign0.45Likely Benign-0.01Likely Benign-0.47Neutral0.801Possibly Damaging0.315Benign1.83Pathogenic0.57Tolerated-1-1-2.6-30.09
c.1154C>GS385W
(3D Viewer)
C2Benign 16-33438059-C-G-9.353Likely Pathogenic0.362AmbiguousLikely Benign0.373Likely Benign0.53Ambiguous0.20.69Ambiguous0.61Ambiguous0.00Likely Benign-0.84Neutral0.986Probably Damaging0.968Probably Damaging4.63Benign0.00Affected4.323-2-3-0.199.14260.4-71.20.51.30.70.4UncertainSer385 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus hydrophobic residues like tryptophan are rarely tolerated. Although no major negative structural effects are observed in the variant simulations, Trp385 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effects on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.10.1016/j.ajhg.2020.11.011
c.1556A>CE519A
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-8.557Likely Pathogenic0.904Likely PathogenicAmbiguous0.384Likely Benign-0.05Likely Benign0.00.55Ambiguous0.25Likely Benign0.00Likely Benign-5.23Deleterious0.999Probably Damaging0.998Probably Damaging3.33Benign0.10Tolerated3.37350-15.3-58.04162.483.5-0.10.1-0.20.0XPotentially BenignGlu519 is located at the beginning of an α-α loop between the two α-helices (res. Gly502-Tyr518 and Ala533-Val560). In the WT simulations, the carboxylate side chain of Glu519 does not make any specific interactions. Accordingly, the Ala residue swap does not show any negative structural effects in the variant simulations. However, it should be noted that Glu519 faces the missing part of the N-terminal in the model, and thus its potential role in maintaining the tertiary structure might be de-emphasized in the current model.
c.2003C>TS668F
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-15.047Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.643Likely Pathogenic16.72Destabilizing5.011.07Destabilizing13.90Destabilizing0.00Likely Benign-5.98Deleterious0.999Probably Damaging0.935Probably Damaging3.18Benign0.00Affected3.3828-3-23.660.10250.9-59.6-0.10.10.00.1XXXPotentially PathogenicIn the WT simulations, the hydroxyl side chain of Ser668, located on an α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), forms hydrogen bonds with the backbone carbonyl groups of Leu664, Tyr665, and Glu666, as well as the guanidinium group of Arg573 on a nearby α-helix (res. Arg563-Glu578). In the variant simulations, the side chain of Phe668 cannot maintain the same hydrogen-bond network. Due to its larger size, it moves away to avoid steric hindrance. In the WT simulations, a network of hydrogen bonds between several residues (e.g., Asn669, Lys566, and Glu666) keeps both α-helices and the proceeding loop (res. Asn669-Asp684) tightly connected, but this setup is not present in the variant simulations. Additionally, in the variant simulations, the side chain of Arg573 shifts to form a more stable salt bridge with the carboxylate group of Glu582 instead of hydrogen bonding with Ser668 as in the WT simulations.
c.958G>AV320I
(3D Viewer)
Likely BenignC2Uncertain 1-5.220Likely Benign0.111Likely BenignLikely Benign0.027Likely Benign-0.27Likely Benign0.20.66Ambiguous0.20Likely Benign0.01Likely Benign-0.21Neutral0.198Benign0.114Benign1.77Pathogenic0.45Tolerated3.3823340.314.03
c.877C>TR293C
(3D Viewer)
Likely PathogenicC2Uncertain 16-33437782-C-T31.86e-6-12.844Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.579Likely Pathogenic1.38Ambiguous0.10.62Ambiguous1.00Ambiguous0.02Likely Benign-7.35Deleterious1.000Probably Damaging0.998Probably Damaging1.46Pathogenic0.00Affected3.3823-4-37.0-53.05226.096.50.00.00.10.1XXXPotentially PathogenicThe guanidinium group of the Arg293 side chain, located in an anti-parallel β sheet strand (res. Met289-Pro298), packs against the phenol ring of the Tyr281 side chain or forms a salt bridge with the carboxylate group of Glu283 on the outer side of the C2 domain. The positively charged guanidinium side chain of arginine is on the outside surface of the hydrophobic C2 domain, resulting in a twist in the β strand. Although this twist is maintained in the variant simulations, replacing the positively charged residue with a more hydrophobic one, such as cysteine, could remove the twist during protein folding.Because Arg293 is positioned at the C2 and PH domain interface, the residue swap could significantly impact the tertiary structure assembly. Notably, Arg293 is located at the SynGAP-Ras interface, and its role in complex formation cannot be fully understood through solvent-only simulations.
c.1339G>CV447L
(3D Viewer)
Likely BenignGAPUncertain 1-5.136Likely Benign0.491AmbiguousLikely Benign0.180Likely Benign-1.13Ambiguous0.10.54Ambiguous-0.30Likely Benign0.03Likely Benign-0.29Neutral0.947Possibly Damaging0.851Possibly Damaging3.61Benign0.90Tolerated3.373212-0.414.03
c.901G>AA301T
(3D Viewer)
Likely BenignC2Uncertain 56-33437806-G-A21.24e-6-3.448Likely Benign0.070Likely BenignLikely Benign0.150Likely Benign0.36Likely Benign0.2-0.33Likely Benign0.02Likely Benign0.03Likely Benign-0.25Neutral0.997Probably Damaging0.989Probably Damaging4.15Benign0.22Tolerated4.321410-2.530.03219.8-42.8-0.10.0-0.50.2UncertainThe methyl group of Ala301, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Met289-Pro298, res. Thr305-Asn315), points outward from the β hairpin loop, and its backbone atoms do not participate in the loop formation in the WT simulations. In the variant simulations, the hydroxyl group of the Thr301 side chain also mostly points outward; however, the guanidinium group of Arg299 is moved away from its central hairpin loop position.β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. Due to its location near the membrane surface, the residue swap could also affect the C2 loop dynamics and SynGAP-membrane association. However, this is beyond the scope of the solvent-only simulations to unravel.
c.899C>TS300F
(3D Viewer)
Likely PathogenicC2Uncertain 1-10.222Likely Pathogenic0.353AmbiguousLikely Benign0.117Likely Benign-0.29Likely Benign0.40.16Likely Benign-0.07Likely Benign0.04Likely Benign-2.66Deleterious0.975Probably Damaging0.596Possibly Damaging1.52Pathogenic0.01Affected3.4719-3-23.660.10233.6-67.6-0.10.00.40.2XXPotentially PathogenicThe hydroxyl group of the Ser300 side chain, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Met289-Pro298, res. Thr305-Asn315), hydrogen bonds with the guanidinium group of Arg299 and the backbone amide group and side chain of Ser302. Thus, in the WT simulations, it contributes to the β hairpin stability. In the variant simulations, the phenol ring of Phe300 cannot form any side chain-related hydrogen bonds, and Arg299 is moved away from its central hairpin loop position.β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. Due to its location near the membrane surface, the residue swap could also affect the C2 loop dynamics and SynGAP-membrane association. However, this is beyond the scope of the solvent-only simulations to unravel.
c.1851G>TE617D
(3D Viewer)
Likely BenignGAPUncertain 1-1.349Likely Benign0.241Likely BenignLikely Benign0.322Likely Benign0.12Likely Benign0.10.80Ambiguous0.46Likely Benign0.07Likely Benign-0.01Neutral0.994Probably Damaging0.979Probably Damaging-1.35Pathogenic0.88Tolerated3.3735230.0-14.03
c.1147G>TG383W
(3D Viewer)
C2Uncertain 16-33438052-G-T16.22e-7-10.161Likely Pathogenic0.439AmbiguousLikely Benign0.469Likely Benign5.81Destabilizing3.64.44Destabilizing5.13Destabilizing0.08Likely Benign-1.01Neutral0.959Probably Damaging0.704Possibly Damaging4.09Benign0.00Affected4.327-2-7-0.5129.16
c.1594A>CT532P
(3D Viewer)
Likely BenignGAPBenign 1-2.143Likely Benign0.061Likely BenignLikely Benign0.201Likely Benign-0.30Likely Benign0.20.06Likely Benign-0.12Likely Benign0.08Likely Benign-0.90Neutral0.005Benign0.008Benign-1.28Pathogenic0.18Tolerated3.37350-1-0.9-3.99174.235.10.40.00.10.0XPotentially BenignThr532 is located on an α-α loop between the two α-helices (res. Gly502-Tyr518 and Ala533-Val560) facing the membrane. In the WT simulations, the hydroxyl group of Thr532 occasionally forms hydrogen bonds with the backbone atoms of other loop residues without any specific interaction. In the variant simulations, the Pro532 residue swap does not cause structural changes. Although hydrophilic residues seem more favorable in the loop, the pyrrolidine side chain of proline is well suited for unstructured protein regions such as loops. However, due to its location at the SynGAP-membrane interface, the effect of the residue swap cannot be fully addressed using the SynGAP solvent-only simulations.
c.2116G>AE706K
(3D Viewer)
GAPUncertain 1-10.519Likely Pathogenic0.833Likely PathogenicAmbiguous0.080Likely Benign1.17Ambiguous0.10.51Ambiguous0.84Ambiguous0.08Likely Benign-1.51Neutral0.345Benign0.028Benign4.15Benign0.52Tolerated3.471001-0.4-0.94187.149.20.00.00.40.1XUncertainThe carboxylate side chain of Glu706, located at the end and outer surface of an α-helix (res. Thr704-Gly712), forms a salt bridge with Lys710 and a hydrogen bond with its own backbone amino group at the helix end in the WT simulations. Although Lys706 is unable to make these transient interactions in the variant simulations, there is no apparent negative effect on the protein structure due to the residue swap. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.1118G>TG373V
(3D Viewer)
Likely BenignC2Uncertain 16-33438023-G-T65.03e-6-6.062Likely Benign0.112Likely BenignLikely Benign0.428Likely Benign5.32Destabilizing3.20.82Ambiguous3.07Destabilizing0.09Likely Benign-0.98Neutral0.007Benign0.001Benign3.90Benign0.00Affected3.5316-1-34.642.08207.6-68.11.91.1-0.60.1UncertainGly373 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus hydrophobic residues like valine are rarely tolerated. Although no negative structural effects are observed in the variant simulations, Val373 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effect on the Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.611C>GS204C
(3D Viewer)
Likely BenignPHUncertain 1-6.613Likely Benign0.127Likely BenignLikely Benign0.148Likely Benign0.65Ambiguous0.4-1.13Ambiguous-0.24Likely Benign0.10Likely Benign-0.64Neutral0.978Probably Damaging0.753Possibly Damaging4.13Benign0.05Affected3.44100-13.316.06223.6-13.80.60.30.00.2XUncertainThe hydroxyl-containing Ser204, located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by the thiol-containing cysteine. In the WT simulations, Ser204 simultaneously forms hydrogen bonds with the backbone carbonyl of Asp201 and the hydroxyl group of Thr224, helping to stabilize the two anti-parallel β strands (res. Ile205-Lys207 and Cys219-Thr223) at the end of the β sheet. Since the thiol group of cysteine forms weaker hydrogen bonds than the hydroxyl group of serine, Cys204 does not maintain the hydrogen bond network as stably as Ser204 in the variant simulations. However, because the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.2105A>GQ702R
(3D Viewer)
GAPUncertain 1-7.894In-Between0.348AmbiguousLikely Benign0.294Likely Benign-0.31Likely Benign0.10.63Ambiguous0.16Likely Benign0.13Likely Benign-3.14Deleterious0.909Possibly Damaging0.889Possibly Damaging3.43Benign0.02Affected3.471011-1.028.06270.3-52.90.00.00.00.1XPotentially PathogenicThe carboxamide side chain of Gln702 is located at the end and outer surface of an α-helix (res. Leu685-Gln702), where it does not directly form hydrogen bonds with any residues in the WT simulations. In the variant simulations, the positively charged guanidinium group of Arg702 forms a salt bridge with the negatively charged carboxylate group of Glu698 on the same helix and/or hydrogen bonds with the backbone carbonyl group of Ala438 on an opposite α-helix (res. Tyr428-Glu436). Consequently, the residue swap could strengthen the tertiary structure assembly, which could have either positive or negative effects on its function.
c.700C>TR234W
(3D Viewer)
Likely PathogenicPHUncertain 16-33435551-C-T31.86e-6-12.625Likely Pathogenic0.947Likely PathogenicAmbiguous0.805Likely Pathogenic0.96Ambiguous0.30.69Ambiguous0.83Ambiguous0.13Likely Benign-5.52Deleterious0.997Probably Damaging0.803Possibly Damaging5.76Benign0.01Affected3.40142-33.630.03262.839.6-0.10.0-0.20.2XPotentially PathogenicThe guanidinium group of Arg234, located in a β-α loop between an anti-parallel β sheet strand (residues Gly227-Phe231) and an α helix (res. Ala236-Val250), forms a salt bridge with the carboxylate group of Glu238 in the α helix. Occasionally, it also bonds with the GAP domain residues Ser678 and Glu680. Thus, the positively charged Arg234 could contribute to the tertiary structure assembly between the PH and GAP domains. In contrast, the indole side chain of Trp234 in the variant is located on the protein surface in the variant simulations and is unable to form any interactions.
c.2029A>TS677C
(3D Viewer)
Likely BenignGAPBenign 1-8.496Likely Pathogenic0.076Likely BenignLikely Benign0.153Likely Benign-0.51Ambiguous0.3-0.30Likely Benign-0.41Likely Benign0.15Likely Benign-2.41Neutral0.932Possibly Damaging0.222Benign3.25Benign0.04Affected3.4123-103.316.06
c.1126G>TG376CC2Uncertain 1-7.686In-Between0.125Likely BenignLikely Benign0.560Likely Pathogenic2.56Destabilizing0.50.22Likely Benign1.39Ambiguous0.16Likely Benign-1.15Neutral1.000Probably Damaging1.000Probably Damaging1.32Pathogenic0.01Affected-3-32.946.09
c.1136C>GS379W
(3D Viewer)
C2Uncertain 16-33438041-C-G-8.898Likely Pathogenic0.388AmbiguousLikely Benign0.520Likely Pathogenic4.32Destabilizing3.43.56Destabilizing3.94Destabilizing0.16Likely Benign-1.02Neutral0.998Probably Damaging0.844Possibly Damaging3.82Benign0.01Affected4.3211-2-3-0.199.14271.3-75.71.41.00.60.5UncertainSer379 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and thus hydrophobic residues like tryptophan are rarely tolerated. Although no major negative structural effects are observed in the variant simulations, Trp379 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. However, since the effect on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn
c.1667A>GN556S
(3D Viewer)
GAPUncertain 16-33438910-A-G31.86e-6-6.576Likely Benign0.197Likely BenignLikely Benign0.449Likely Benign0.52Ambiguous0.10.14Likely Benign0.33Likely Benign0.16Likely Benign-3.60Deleterious1.000Probably Damaging0.989Probably Damaging-1.22Pathogenic0.14Tolerated3.3735112.7-27.03198.831.00.00.0-0.50.2XPotentially BenignAsn556 is located on the outer surface of an α-helix (res. Ala533-Val560). The carboxamide group of Asn556 forms hydrogen bonds with nearby residues such as Lys553 and Cys552. It also forms a hydrogen bond with the backbone carbonyl group of Cys552, which weakens the α-helix integrity. In the variant simulations, the hydroxyl group of Ser556 forms a more stable hydrogen bond with the backbone carbonyl oxygen of the same helix residue, Cys552, compared to Asn556 in the WT. Serine has a slightly lower propensity to reside in an α-helix than asparagine, which may exacerbate the negative effect on the α-helix integrity. However, the residue swap does not cause negative structural effects during the simulations.
c.1586T>CI529T
(3D Viewer)
Likely BenignGAPUncertain 1-0.539Likely Benign0.336Likely BenignLikely Benign0.343Likely Benign0.22Likely Benign0.20.16Likely Benign0.19Likely Benign0.17Likely Benign0.24Neutral0.872Possibly Damaging0.820Possibly Damaging-1.23Pathogenic0.55Tolerated3.37350-1-5.2-12.05207.229.80.20.00.20.1XPotentially BenignIle529 is located on an α-α loop between the two α-helices (res. Gly502-Tyr518 and Ala533-Val560). In the WT simulations, the sec-butyl side chain of Ile529 faces the membrane interface and shows no specific interactions. In the variant simulations, the hydroxyl group of Thr529 forms a hydrogen bond with the carboxylate side chain of Asp527, but no negative structural changes are observed. However, due to its location near the SynGAP-membrane interface, the effect of the residue swap cannot be fully addressed using the SynGAP solvent-only simulations.
c.1604G>CS535T
(3D Viewer)
Likely BenignGAPBenign 16-33438847-G-C148.67e-6-3.886Likely Benign0.069Likely BenignLikely Benign0.177Likely Benign0.45Likely Benign0.1-0.27Likely Benign0.09Likely Benign0.17Likely Benign-0.81Neutral0.000Benign0.001Benign-1.25Pathogenic0.25Tolerated3.3735110.114.03201.3-17.3-0.10.7-0.20.1XPotentially BenignSer535 is located near the terminal end of an α-helix (res. Ala533-Val560) close to the membrane interface. In the WT simulations, the hydroxyl side chain of Ser535 forms hydrogen bonds with nearby residues (e.g., His539, Glu538) without any specific interactions. These hydrogen bonds disrupt the structure of the terminal end of the α-helix (Ala533-Ser535), causing it to weaken or unfold during the WT simulations. In the variant simulations, Thr535, a hydrophilic residue with a hydroxyl group of almost the same size as Ser, interacts more frequently with the preceding loop residues (e.g., Thr532, Cys531) due to its longer side chain. Regardless, the residue swap is tolerated in the simulations with no negative effects. However, due to its location near the SynGAP-membrane interface, the effect of the residue swap cannot be fully addressed using the SynGAP solvent-only simulations.10.1016/j.ajhg.2020.11.011
c.961C>TR321C
(3D Viewer)
Likely PathogenicC2Conflicting 26-33437866-C-T95.58e-6-10.025Likely Pathogenic0.387AmbiguousLikely Benign0.495Likely Benign0.57Ambiguous0.10.56Ambiguous0.57Ambiguous0.18Likely Benign-4.59Deleterious1.000Probably Damaging0.998Probably Damaging1.89Pathogenic0.01Affected3.3823-3-47.0-53.05
c.1150G>AG384S
(3D Viewer)
Likely BenignC2Uncertain 16-33438055-G-A16.22e-7-5.243Likely Benign0.090Likely BenignLikely Benign0.315Likely Benign1.92Ambiguous0.21.66Ambiguous1.79Ambiguous0.19Likely Benign-0.67Neutral0.980Probably Damaging0.968Probably Damaging1.33Pathogenic0.04Affected4.32210-0.430.03202.4-49.80.51.0-0.20.0UncertainGly384 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and so they are rich in glycines, prolines, and, to a lesser extent, small hydrophilic residues to ensure maximum flexibility. Thus, the variant’s Ser384 is potentially tolerated in the Ω loop, although the hydroxyl group of Ser384 forms various hydrogen bonds with several other loop residues in the variant simulations. However, since the effects on Gly-rich Ω loop dynamics can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1153T>CS385P
(3D Viewer)
Likely BenignC2Uncertain 16-33438058-T-C-5.431Likely Benign0.123Likely BenignLikely Benign0.385Likely Benign0.91Ambiguous0.6-0.90Ambiguous0.01Likely Benign0.19Likely Benign-0.26Neutral0.676Possibly Damaging0.693Possibly Damaging4.63Benign0.04Affected4.3231-1-0.810.04210.318.51.80.90.30.0UncertainSer385 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364, res. Ala399-Ile411). Because the Ω loop is assumed to directly interact with the membrane, it moves arbitrarily throughout the WT solvent simulations. The Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play major roles in protein functions that require flexibility, and so they are rich in glycine residues, prolines, and, to a lesser extent, small hydrophilic residues to ensure maximum flexibility. Thus, the variant’s Pro385 is potentially tolerated in the Ω loop. However, since the effects on Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1441C>TH481Y
(3D Viewer)
Likely PathogenicGAPLikely Benign 16-33438473-C-T169.91e-6-10.910Likely Pathogenic0.565Likely PathogenicLikely Benign0.256Likely Benign-0.53Ambiguous0.1-0.46Likely Benign-0.50Ambiguous0.20Likely Benign-3.32Deleterious0.988Probably Damaging0.979Probably Damaging3.40Benign0.59Tolerated3.3733021.926.03256.5-44.40.00.00.20.2XXUncertainThe imidazole ring of the His481 side chain is located in a short helical structure (res. Glu480-Leu482) within an α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. In the WT simulations, His481 alternately stacks against Arg485, Arg587, and Glu480 without a definite role. In the variant simulations, Tyr481 also alternately stacks with nearby arginine residues, including Arg485, Arg587, and Arg479. The interaction between Tyr481 and Arg479 affects the α-α loop, causing it to fold into a distorted helical structure, an effect that might be more pronounced during protein folding. Finally, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.910G>AD304N
(3D Viewer)
C2Uncertain 1-6.194Likely Benign0.391AmbiguousLikely Benign0.345Likely Benign0.30Likely Benign0.1-0.08Likely Benign0.11Likely Benign0.21Likely Benign-4.18Deleterious0.999Probably Damaging0.997Probably Damaging1.81Pathogenic0.03Affected3.3823120.0-0.98
c.603T>AD201E
(3D Viewer)
Likely BenignPHBenign 1-2.640Likely Benign0.406AmbiguousLikely Benign0.165Likely Benign0.42Likely Benign0.21.99Ambiguous1.21Ambiguous0.23Likely Benign-0.69Neutral0.633Possibly Damaging0.108Benign4.30Benign1.00Tolerated3.469320.014.03258.7-24.80.90.1-0.30.2XUncertainAsp201, an acidic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another acidic residue, glutamate. The carboxylate groups of both Asp201 and Glu201 side chains form hydrogen bonds with the hydroxyl group of Ser221 in the simulations. Due to its shorter side chain, Asp201 can also hydrogen bond with the backbone amide groups of neighboring loop residues Ser204 and Asp203. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.603T>GD201E
(3D Viewer)
Likely BenignPHConflicting 26-33435245-T-G201.24e-5-2.640Likely Benign0.406AmbiguousLikely Benign0.165Likely Benign0.42Likely Benign0.21.99Ambiguous1.21Ambiguous0.23Likely Benign-0.69Neutral0.633Possibly Damaging0.108Benign4.30Benign1.00Tolerated3.469320.014.03258.7-24.80.90.1-0.30.2XUncertainAsp201, an acidic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another acidic residue, glutamate. The carboxylate groups of both Asp201 and Glu201 side chains form hydrogen bonds with the hydroxyl group of Ser221 in the simulations. Due to its shorter side chain, Asp201 can also hydrogen bond with the backbone amide groups of neighboring loop residues Ser204 and Asp203. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.1131G>AM377I
(3D Viewer)
Likely BenignC2Uncertain 16-33438036-G-A16.23e-7-2.895Likely Benign0.212Likely BenignLikely Benign0.227Likely Benign0.76Ambiguous0.30.54Ambiguous0.65Ambiguous0.24Likely Benign-0.41Neutral0.000Benign0.001Benign5.46Benign0.26Tolerated4.3212122.6-18.03
c.719A>GD240GLikely PathogenicPHUncertain 1-12.825Likely Pathogenic0.951Likely PathogenicAmbiguous0.912Likely Pathogenic1.85Ambiguous0.12.72Destabilizing2.29Destabilizing0.24Likely Benign-6.19Deleterious0.993Probably Damaging0.984Probably Damaging5.79Benign0.01Affected1-13.1-58.04
c.865A>GM289V
(3D Viewer)
Likely BenignC2Benign 1-4.239Likely Benign0.117Likely BenignLikely Benign0.150Likely Benign1.09Ambiguous0.1-0.27Likely Benign0.41Likely Benign0.24Likely Benign-0.36Neutral0.136Benign0.054Benign1.80Pathogenic1.00Tolerated3.3823212.3-32.06204.251.00.00.00.20.0XPotentially BenignThe hydrophobic residue Met289, located in a β hairpin linking two anti-parallel β sheet strands (res. Met289-Arg299, res. Arg272-Leu286), is swapped for another hydrophobic residue, valine. In the variant simulations, the branched hydrocarbon side chain of Val289 packs against the phenol group of the Tyr291 side chain but is unable to form methionine-aromatic interactions. β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. However, based on the simulations, the residue swap does not cause adverse effects on the structure.
c.1354G>AV452I
(3D Viewer)
GAPUncertain 1-8.985Likely Pathogenic0.361AmbiguousLikely Benign0.218Likely Benign-0.08Likely Benign0.10.51Ambiguous0.22Likely Benign0.25Likely Benign-0.99Neutral0.947Possibly Damaging0.851Possibly Damaging3.26Benign0.05Affected430.314.03
c.1559C>TS520F
(3D Viewer)
Likely PathogenicGAPUncertain 1-12.541Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.833Likely Pathogenic-1.20Ambiguous0.40.39Likely Benign-0.41Likely Benign0.25Likely Benign-5.57Deleterious0.999Probably Damaging0.996Probably Damaging-1.36Pathogenic0.00Affected3.3735-2-33.660.10
c.1966G>CE656Q
(3D Viewer)
GAPUncertain 16-33441225-G-C16.20e-7-9.145Likely Pathogenic0.766Likely PathogenicLikely Benign0.249Likely Benign-0.14Likely Benign0.0-0.81Ambiguous-0.48Likely Benign0.25Likely Benign-2.29Neutral0.980Probably Damaging0.528Possibly Damaging3.46Benign0.02Affected3.3924220.0-0.98224.31.70.00.10.10.0XPotentially BenignThe carboxylate side chain of Glu656, located on an α helix (res. Ser641-Glu666), frequently forms a hydrogen bond with the nearby residue Ser659 on the same α helix. In the variant simulations, the carboxamide side chain of Gln656 alternatively forms a hydrogen bond with either Ser659 or Glu548 on an opposing helix (res. Ala533-Val560).Although the frequent interaction between Gln656 and Glu548 may strengthen or stabilize the tertiary structure assembly, the effect is likely to be marginal.
c.1667A>TN556I
(3D Viewer)
Likely PathogenicGAPLikely Benign 16-33438910-A-T-13.391Likely Pathogenic0.929Likely PathogenicAmbiguous0.761Likely Pathogenic0.64Ambiguous0.00.17Likely Benign0.41Likely Benign0.26Likely Benign-7.52Deleterious1.000Probably Damaging0.999Probably Damaging-1.35Pathogenic0.02Affected3.3735-3-28.0-0.94
c.2168C>TT723I
(3D Viewer)
Likely BenignGAPLikely Benign 16-33441633-C-T21.24e-6-2.591Likely Benign0.120Likely BenignLikely Benign0.045Likely Benign-0.39Likely Benign0.0-0.20Likely Benign-0.30Likely Benign0.26Likely Benign-2.09Neutral0.088Benign0.030Benign3.39Benign0.03Affected3.5080-15.212.05252.3-31.60.00.0-0.20.2XUncertainThe hydroxyl group of Thr723, located on the outer surface of an α-helix (res. Leu714-Arg726), continuously forms hydrogen bonds with the backbone carbonyl of Asn719 in the WT simulations, potentially lowering the stability of the α-helix. In the variant simulations, the sec-butyl side chain of Ile723 cannot form any hydrogen bonds, which, in theory, could increase the helix stability. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.1712C>TS571L
(3D Viewer)
Likely PathogenicGAPUncertain 16-33440764-C-T16.23e-7-11.651Likely Pathogenic0.660Likely PathogenicLikely Benign0.841Likely Pathogenic-1.53Ambiguous0.1-1.05Ambiguous-1.29Ambiguous0.27Likely Benign-5.61Deleterious1.000Probably Damaging0.996Probably Damaging-1.25Pathogenic0.04Affected3.3735-2-34.626.08
c.859G>TD287Y
(3D Viewer)
Likely PathogenicC2Likely Pathogenic 1-12.877Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.663Likely Pathogenic0.21Likely Benign0.20.48Likely Benign0.35Likely Benign0.27Likely Benign-8.27Deleterious1.000Probably Damaging0.999Probably Damaging1.51Pathogenic0.00Affected3.3823-4-32.248.09257.8-44.4-0.61.60.20.3XXPotentially PathogenicThe carboxylate group of Asp287, located at the beginning of a β hairpin loop linking two anti-parallel β sheet strands (res. Arg279-Leu286, res. Met289-Pro298), maintains a salt bridge with the guanidinium group of Arg324 in the β sheet during the WT simulations. In the variant simulations, the phenol group of the Tyr287 side chain is unable to form a salt bridge with the guanidinium group of Arg324, which could weaken the tertiary structure assembly of the C2 domain. However, the phenol group of Tyr287 frequently stacks with the Arg324 guanidinium side chain, which could help maintain the tertiary structure, especially compared to the D287H variant. The destabilization of the C2 domain could adversely affect the stability of the SynGAP-membrane association.
c.1925A>CK642T
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-12.823Likely Pathogenic0.948Likely PathogenicAmbiguous0.484Likely Benign0.53Ambiguous0.10.30Likely Benign0.42Likely Benign0.28Likely Benign-5.88Deleterious0.872Possibly Damaging0.839Possibly Damaging2.86Benign0.00Affected3.37310-13.2-27.07213.5-8.7-0.30.40.30.2XUncertainThe amino side chain of Lys642, located on the surface of an α helix (res. Ser641-Glu666), is not involved in any interactions in the WT simulations. In the variant simulations, the shorter side chain of Thr642 forms hydrogen bonds with Glu643 and Thr640 on the same α helix.Regardless, Lys642 is positioned directly at the GAP-Ras interface, and in the SynGAP-Ras WT simulations, its amino side chain forms salt bridges with the carboxylate groups of Ras residues Asp33 and Asp38. The shorter Thr642 is more likely to prefer hydrogen bonding with Glu643 and Thr640 on the same α helix, even in the Ras complex. Thus, the effect of the residue swap on the complex formation with the GTPase cannot be explored using solvent-only simulations.
c.2111G>CS704T
(3D Viewer)
Likely BenignGAPUncertain 1-4.930Likely Benign0.265Likely BenignLikely Benign0.071Likely Benign0.80Ambiguous0.00.15Likely Benign0.48Likely Benign0.29Likely Benign-1.72Neutral0.525Possibly Damaging0.107Benign3.45Benign0.07Tolerated3.4710110.114.03201.7-18.00.00.0-0.20.7XPotentially BenignSer704 is located at the end and outer surface of an α-helix (res. Thr704-Gly712), which is connected via a tight turn or loop to another α-helix (res. Asp684-Gln702). The hydroxyl side chain of Ser704 occasionally forms a hydrogen bond with the amide group of Ala707. Similarly, in the variant simulations, the hydroxyl side chain of Thr704 forms hydrogen bonds with the amide groups of Ala707 and Leu708. Thus, the residue swap does not cause any apparent structural change.
c.745G>AA249T
(3D Viewer)
Likely BenignPHUncertain 1-3.564Likely Benign0.805Likely PathogenicAmbiguous0.487Likely Benign1.50Ambiguous0.61.39Ambiguous1.45Ambiguous0.30Likely Benign-0.96Neutral0.990Probably Damaging0.815Possibly Damaging5.65Benign0.40Tolerated3.391510-2.530.03214.5-43.30.00.00.50.2XPotentially BenignThe methyl group of Ala249, located on the surface of an α helix (res. Ala236-Val250) facing an anti-parallel β sheet strand (res. Ile205-Val209), packs against nearby hydrophobic residues such as Leu200, Leu246, and Val250. In the variant simulations, the hydroxyl group of Thr249, which is not suitable for hydrophobic packing, forms a stable hydrogen bond with the backbone carbonyl of Asn245 in the same helix. Although this interaction could theoretically weaken the structural integrity of the α helix, this destabilizing effect is not observed in the variant simulations.
c.1300G>AV434I
(3D Viewer)
Likely BenignGAPUncertain 16-33438205-G-A16.19e-7-6.999Likely Benign0.129Likely BenignLikely Benign0.192Likely Benign-0.04Likely Benign0.00.22Likely Benign0.09Likely Benign0.31Likely Benign-0.82Neutral0.947Possibly Damaging0.851Possibly Damaging3.53Benign0.18Tolerated3.3729430.314.03246.7-27.70.00.00.10.0XPotentially BenignThe iso-propyl side chain of Val434, located at the end of an α helix (res. Met414-Glu436), packs against hydrophobic residues in an interhelix space (e.g., Met430, Ala707, Leu711). In the variant simulations, the sec-butyl group of Ile434 is able to form the same hydrophobic interactions. Accordingly, the residue swap does not negatively affect the protein structure based on the simulations.
c.1976C>TS659F
(3D Viewer)
Likely PathogenicGAPUncertain 1-10.925Likely Pathogenic0.662Likely PathogenicLikely Benign0.194Likely Benign-0.81Ambiguous0.1-0.25Likely Benign-0.53Ambiguous0.32Likely Benign-4.59Deleterious0.806Possibly Damaging0.171Benign3.39Benign0.05Affected3.3828-3-23.660.10221.3-61.20.00.00.60.4XPotentially BenignIn the WT simulations, the hydroxyl group of Ser659, located in a kink in the middle of the long α-helix (res. Ser641-Glu666), forms a hydrogen bond with the carboxylate group of Glu656. However, the phenol ring of the Phe659 side chain cannot form a similar hydrogen bond. Instead, it interacts with the hydrophobic isopropyl side chain of Val555 from the opposing α-helix (res. Ala533-Val560). This residue swap may therefore cause issues during protein folding.
c.878G>AR293HLikely PathogenicC2Uncertain 1-13.009Likely Pathogenic0.973Likely PathogenicLikely Pathogenic0.438Likely Benign4.45Destabilizing2.32.12Destabilizing3.29Destabilizing0.32Likely Benign-4.60Deleterious1.000Probably Damaging0.998Probably Damaging1.45Pathogenic0.04Affected201.3-19.05
c.597C>AN199K
(3D Viewer)
PHUncertain 1-8.198Likely Pathogenic0.686Likely PathogenicLikely Benign0.024Likely Benign-0.19Likely Benign0.10.03Likely Benign-0.08Likely Benign0.33Likely Benign-1.48Neutral0.276Benign0.083Benign4.27Benign0.13Tolerated3.47910-0.414.07207.821.5-0.11.50.10.0XUncertainAsn199, located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by a positively charged lysine. On the protein surface, both the carboxamide group of Asn199 and the amino group of Lys199 side chains can form hydrogen bonds with the backbone carbonyl groups of residues (e.g., Ala249) at the end of an α helix (res. Ala236-Lys251). However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.1405G>AA469T
(3D Viewer)
Likely PathogenicGAPUncertain 1-9.540Likely Pathogenic0.723Likely PathogenicLikely Benign0.527Likely Pathogenic2.26Destabilizing0.11.90Ambiguous2.08Destabilizing0.34Likely Benign-1.46Neutral0.994Probably Damaging0.986Probably Damaging-1.21Pathogenic0.42Tolerated10-2.530.03
c.886T>GS296A
(3D Viewer)
Likely BenignC2Uncertain 1-6.847Likely Benign0.247Likely BenignLikely Benign0.209Likely Benign0.50Ambiguous0.3-0.26Likely Benign0.12Likely Benign0.35Likely Benign-1.79Neutral0.992Probably Damaging0.987Probably Damaging1.97Pathogenic0.65Tolerated3.4016112.6-16.00182.526.6-0.20.1-0.50.0XPotentially PathogenicThe hydroxyl group of the Ser296 side chain, located in an anti-parallel β sheet strand (res. Met289-Pro298), stably hydrogen bonds with the carboxylate group of Asp330 in a neighboring β strand (res. Ala322-Asp332). The backbone carbonyl group of Ser296 also hydrogen bonds with the guanidinium group of Arg279 in another nearby β strand (res. Arg279-Cys285). In the variant simulations, the methyl group of the Ala296 side chain cannot hydrogen bond with Asp330, causing the carboxylate group positioning to fluctuate more than in the WT simulations.Although the residue swap does not seem to affect the anti-parallel β sheet assembly during the simulations, it is possible that the Ser296-Asp330 hydrogen bond plays a crucial role in maintaining the C2 domain fold. Notably, because Ser296 is located near the membrane interface, the potential effect of the residue swap on the SynGAP-membrane association cannot be addressed by solvent-only simulations.
c.1312G>AA438T
(3D Viewer)
Likely BenignGAPConflicting 36-33438217-G-A169.91e-6-5.339Likely Benign0.085Likely BenignLikely Benign0.021Likely Benign0.21Likely Benign0.0-0.07Likely Benign0.07Likely Benign0.36Likely Benign-0.81Neutral0.300Benign0.011Benign4.18Benign0.14Tolerated3.382610-2.530.03214.2-42.7-0.30.1-0.40.1XPotentially BenignThe methyl group of Ala438, located in a four-residue loop connecting two α helices (res. Asn440-Thr458 and Pro413-Glu436), packs against hydrophobic residues from a nearby α helix or loop residues (e.g., Leu703, Val699). In the variant simulations, the methyl group of Thr438 is able to establish similar hydrophobic packing. Moreover, the hydroxyl group also H-bonds with nearby residues, such as the carbonyl group of the neighboring loop residue Pro437. Accordingly, the residue swap does not generate an apparent negative effect on the protein structure based on the simulations.
c.929A>GE310G
(3D Viewer)
Likely PathogenicC2Pathogenic 1-14.132Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.848Likely Pathogenic2.38Destabilizing0.73.56Destabilizing2.97Destabilizing0.36Likely Benign-6.43Deleterious1.000Probably Damaging0.996Probably Damaging1.12Pathogenic0.00Affected3.3819-203.1-72.06
c.1404G>AM468I
(3D Viewer)
Likely PathogenicGAPUncertain 16-33438436-G-A16.20e-7-8.583Likely Pathogenic0.907Likely PathogenicAmbiguous0.508Likely Pathogenic2.53Destabilizing0.21.89Ambiguous2.21Destabilizing0.37Likely Benign-1.06Neutral0.748Possibly Damaging0.886Possibly Damaging-1.10Pathogenic0.07Tolerated3.3731122.6-18.03
c.2050G>AD684N
(3D Viewer)
Likely PathogenicGAPUncertain 1-13.155Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.382Likely Benign1.47Ambiguous0.81.76Ambiguous1.62Ambiguous0.37Likely Benign-4.99Deleterious0.999Probably Damaging0.746Possibly Damaging3.39Benign0.01Affected210.0-0.98
c.718G>AD240NLikely PathogenicPHUncertain 1-12.942Likely Pathogenic0.755Likely PathogenicLikely Benign0.701Likely Pathogenic0.22Likely Benign0.90.47Likely Benign0.35Likely Benign0.37Likely Benign-4.37Deleterious0.993Probably Damaging0.984Probably Damaging5.88Benign0.01Affected210.0-0.98
c.1082A>CQ361P
(3D Viewer)
Likely PathogenicC2Likely Pathogenic 1-13.280Likely Pathogenic0.956Likely PathogenicLikely Pathogenic0.482Likely Benign3.12Destabilizing0.03.45Destabilizing3.29Destabilizing0.38Likely Benign-3.03Deleterious0.996Probably Damaging0.979Probably Damaging1.63Pathogenic0.05Affected3.3725-101.9-31.01
c.860A>CD287A
(3D Viewer)
Likely PathogenicC2Uncertain 1-14.686Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.484Likely Benign0.30Likely Benign0.1-0.04Likely Benign0.13Likely Benign0.40Likely Benign-7.35Deleterious1.000Probably Damaging0.998Probably Damaging1.58Pathogenic0.01Affected3.3823-205.3-44.01
c.1610C>TA537V
(3D Viewer)
Likely BenignGAPLikely Benign 16-33438853-C-T74.34e-6-6.888Likely Benign0.120Likely BenignLikely Benign0.382Likely Benign0.54Ambiguous0.0-0.05Likely Benign0.25Likely Benign0.41Likely Benign-1.97Neutral0.977Probably Damaging0.469Possibly Damaging-1.26Pathogenic0.24Tolerated3.3735002.428.05220.3-45.10.00.0-0.70.1XPotentially BenignAla537 is located on the outer surface of an α-helix (res. Ala533-Val560). The methyl group of Ala537 is on the surface and does not form any interactions. In the variant simulations, the iso-propyl side chain of Val537 is also on the surface, similar to Ala537 in the WT, causing no negative structural effects.
c.1456G>AE486K
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.545Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.435Likely Benign0.06Likely Benign0.10.37Likely Benign0.22Likely Benign0.41Likely Benign-3.58Deleterious1.000Probably Damaging0.988Probably Damaging3.40Benign0.12Tolerated3.373501-0.4-0.94206.852.1-0.30.10.20.0XXUncertainGlu486 is located in an α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. It is adjacent to the arginine finger (Arg485) and is expected to closely interact with Ras. The residue swap could affect complex formation with the GTPase and its activation. In the WT simulations, the carboxylate group of Glu486 forms salt bridges with Arg485 and Arg475 on the preceding α-helix (res. Ala461-Phe476). In the variant simulations, Lys486 does not form any specific interactions. Although the amino group of the Lys486 side chain cannot form these salt bridges, no negative effects on the protein structure are observed. Nevertheless, the potential role of Glu486 in SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations, and no definite conclusions can be drawn.
c.2015C>TT672M
(3D Viewer)
GAPConflicting 26-33441274-C-T191.18e-5-9.472Likely Pathogenic0.174Likely BenignLikely Benign0.127Likely Benign0.31Likely Benign0.41.52Ambiguous0.92Ambiguous0.41Likely Benign-4.34Deleterious0.993Probably Damaging0.520Possibly Damaging3.39Benign0.00Affected3.4025-1-12.630.09231.9-52.91.10.10.50.0XXPotentially PathogenicThe hydroxyl group of Thr672, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop itself, such as Lys566, Glu666, and Asn669. Met672 can only form a hydrogen bond with the amino group of the Lys566 side chain via its backbone carbonyl group. Nevertheless, the Lys566-Glu666 salt bridge forms intermittently. This is possible because Asn669 keeps the carboxylate group of Glu666 in the vicinity through hydrogen bonding, and the hydrophobic side chain of Met stays mostly rotated away from the salt bridge. Consequently, no drastic disruption of the hydrogen-bond network that keeps the loop close to the helices occurs in the variant simulations.
c.600G>CL200F
(3D Viewer)
PHUncertain 16-33435242-G-C21.24e-6-7.606In-Between0.592Likely PathogenicLikely Benign0.094Likely Benign1.00Ambiguous0.51.45Ambiguous1.23Ambiguous0.43Likely Benign-1.97Neutral0.997Probably Damaging0.916Probably Damaging4.02Benign0.17Tolerated3.46920-1.034.02250.4-15.10.60.20.50.0XUncertainLeu200, a hydrophobic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another hydrophobic residue, phenylalanine. Both the phenyl group of Phe200 and the branched iso-butyl hydrocarbon sidechain of Leu200 occupy an inward hydrophobic niche (e.g., Leu246, Val222, Phe231) during the simulations. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.953C>TP318L
(3D Viewer)
Likely PathogenicC2Uncertain 36-33437858-C-T31.86e-6-10.090Likely Pathogenic0.958Likely PathogenicLikely Pathogenic0.624Likely Pathogenic1.33Ambiguous0.10.26Likely Benign0.80Ambiguous0.43Likely Benign-8.96Deleterious1.000Probably Damaging0.999Probably Damaging1.82Pathogenic0.03Affected3.3823-3-35.416.04228.6-68.9-0.70.7-0.40.1XPotentially BenignThe cyclic five-membered pyrrolidine ring of Pro318, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Asp330-Ala322, res. Thr305-Asn315), packs against the hydrophobic side chain of Ile205 at the end of the anti-parallel β sheet in the PH domain. In the variant simulations, the iso-butyl side chain of Leu318 is unable to do the same, potentially weakening the PH and C2 domain association. Importantly, the residue swap could also affect loop formation during folding, as proline can make tighter turns than leucine. Because the residue swap could affect the C2 domain stability, it could also negatively impact the SynGAP-membrane association.
c.1453C>TR485C
(3D Viewer)
Likely PathogenicGAPUncertain 26-33438485-C-T95.58e-6-14.294Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.597Likely Pathogenic1.00Ambiguous0.10.26Likely Benign0.63Ambiguous0.44Likely Benign-7.96Deleterious1.000Probably Damaging1.000Probably Damaging1.90Pathogenic0.00Affected3.3735-4-37.0-53.05225.599.6-0.10.0-0.30.2XUncertainThe guanidinium group of Arg485 is located in a short helical structure (res. Glu480-Leu482) within an α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. The side chain of Arg485 acts as the “arginine finger” of SynGAP, playing a crucial role in Ras-GTPase activation. Consequently, the residue swap inhibits the conversion of GTP to GDP at the enzyme’s active site. Although no negative effects on the protein structure are observed during the simulations, no definite conclusions can be drawn due to the critical role of Arg485 in GTPase activation.
c.2115G>CK705N
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-9.767Likely Pathogenic0.925Likely PathogenicAmbiguous0.183Likely Benign0.74Ambiguous0.00.37Likely Benign0.56Ambiguous0.44Likely Benign-3.12Deleterious0.996Probably Damaging0.876Possibly Damaging3.37Benign0.02Affected3.4710100.4-14.07221.4-20.20.00.00.00.1XUncertainThe amino side chain of Lys705, located at the end and outer surface of an α-helix (res. Thr704-Gly712), does not form any interactions in the WT simulations. In the variant simulations, the carboxamide side chain of Asn705 briefly forms a salt bridge with Glu706. However, there is no apparent difference between the systems. Due to the model ending abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.1055C>AT352N
(3D Viewer)
Likely BenignC2Likely Benign 16-33437960-C-A21.24e-6-4.817Likely Benign0.117Likely BenignLikely Benign0.027Likely Benign0.20Likely Benign0.0-0.04Likely Benign0.08Likely Benign0.45Likely Benign-0.92Neutral0.255Benign0.057Benign1.75Pathogenic0.19Tolerated3.372500-2.813.00208.4-14.5-0.20.1-0.10.0XPotentially BenignThr352 is located in a short α helical section within a loop connecting two β strands (res. Gly341-Pro349, res. Thr359-Pro364) originating from two different anti-parallel β sheets of the C2 domain. In the WT simulations, the side chain hydroxyl and backbone amide groups of Thr354 form hydrogen bonds with the backbone carbonyl group of Pro349 at the end of the preceding β strand. This arrangement likely stabilizes the α helical section and aids in folding, keeping the short secondary structure element intact in the variant simulations. However, the carboxamide group of the Asn352 side chain does not form hydrogen bonds with the backbone carbonyl group of Pro349. Instead, it packs against the cyclic ring and forms hydrogen bonds with the phenol group of the Tyr363 side chain in the other β strand.
c.1003C>TR335C
(3D Viewer)
Likely PathogenicC2Uncertain 16-33437908-C-T16.20e-7-14.354Likely Pathogenic0.938Likely PathogenicAmbiguous0.277Likely Benign0.53Ambiguous0.10.85Ambiguous0.69Ambiguous0.46Likely Benign-5.69Deleterious1.000Probably Damaging0.998Probably Damaging1.67Pathogenic0.01Affected3.3822-3-47.0-53.05
c.1463C>TT488M
(3D Viewer)
Likely PathogenicGAPUncertain 16-33438495-C-T21.24e-6-12.459Likely Pathogenic0.973Likely PathogenicLikely Pathogenic0.746Likely Pathogenic0.66Ambiguous0.31.62Ambiguous1.14Ambiguous0.46Likely Benign-5.70Deleterious1.000Probably Damaging0.999Probably Damaging3.21Benign0.00Affected3.3735-1-12.630.09
c.1973G>AG658D
(3D Viewer)
GAPUncertain 16-33441232-G-A31.86e-6-7.786In-Between0.442AmbiguousLikely Benign0.144Likely Benign-0.40Likely Benign0.1-0.59Ambiguous-0.50Ambiguous0.46Likely Benign-2.64Deleterious0.008Benign0.005Benign3.53Benign0.38Tolerated3.39241-1-3.158.04219.8-84.30.00.00.20.1XPotentially PathogenicGly658, located on the outer surface of an α helix (res. Ser641-Glu666), weakens the helix integrity at that spot, which is necessary for the kink in the middle of the long helix. In the variant simulations, the carboxylic acid side chain of Asp658 is on the surface of the α helix and is not involved in any interactions. However, aspartate is not as effective a breaker of the secondary structure element as glycine, which may lead to misfolding.
c.2158G>AD720N
(3D Viewer)
Likely PathogenicGAPLikely Benign 16-33441623-G-A53.10e-6-9.135Likely Pathogenic0.654Likely PathogenicLikely Benign0.289Likely Benign0.01Likely Benign0.0-0.20Likely Benign-0.10Likely Benign0.46Likely Benign-3.74Deleterious1.000Probably Damaging0.995Probably Damaging2.18Pathogenic0.01Affected3.509120.0-0.98
c.1169G>AG390E
(3D Viewer)
C2Uncertain 1-7.913In-Between0.646Likely PathogenicLikely Benign0.575Likely Pathogenic2.61Destabilizing0.94.28Destabilizing3.45Destabilizing0.47Likely Benign-0.87Neutral0.276Benign0.045Benign1.32Pathogenic0.05Affected4.3280-2-3.172.06241.5-108.40.60.5-0.10.1UncertainGly390 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364 and res. Ala399-Ile411). The Ω loop is assumed to directly interact with the membrane, and it is observed to move arbitrarily throughout the WT solvent simulations. This loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone.Ω loops are known to play significant roles in protein functions that require flexibility, and so they are rich in glycine residues, prolines, and to a lesser extent, small hydrophilic residues to ensure maximum flexibility. Thus, the variant’s Glu390 may not be as well tolerated in the Ω loop. Additionally, the carboxylate group of Glu390 occasionally forms H-bonds with other loop residues in the variant simulations. The interaction between the acidic carboxylate side chain and the acidic membrane lipids may further influence the SynGAP-membrane complex. However, since the effects on the Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1600T>CS534P
(3D Viewer)
Likely BenignGAPUncertain 16-33438843-T-C31.86e-6-5.056Likely Benign0.265Likely BenignLikely Benign0.203Likely Benign-0.40Likely Benign0.20.35Likely Benign-0.03Likely Benign0.47Likely Benign-3.81Deleterious0.993Probably Damaging0.993Probably Damaging3.32Benign0.05Affected3.3735-11-0.810.04
c.878G>CR293P
(3D Viewer)
Likely PathogenicC2Likely Pathogenic 1-16.275Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.497Likely Benign3.62Destabilizing0.49.06Destabilizing6.34Destabilizing0.47Likely Benign-6.43Deleterious1.000Probably Damaging0.999Probably Damaging1.45Pathogenic0.01Affected3.38230-22.9-59.07202.3132.00.10.00.10.1XXXPotentially PathogenicThe guanidinium group of the Arg293 side chain, located in an anti-parallel β sheet strand (res. Met289-Pro298), packs against the phenol ring of the Tyr281 side chain or forms a salt bridge with the carboxylate group of Glu283 on the outer side of the C2 domain. In the WT simulations, the positively charged side chain of arginine remains outside the hydrophobic C2 domain, resulting in a twist in the β strand. The backbone amide bond of Arg293 potentially maintains this twist by forming a hydrogen bond with the carbonyl group of His210 or the hydroxyl group of Ser211 in the anti-parallel β sheet.Although this twist is also maintained in the variant simulations, replacing the positively charged residue with proline, which lacks the backbone amide group altogether, causes the β strand to unfold. Because Arg293 is positioned at the C2 and PH domain interface, the residue swap could significantly impact the tertiary structure assembly. Notably, Arg293 is located at the SynGAP-Ras interface, and its role in complex formation cannot be fully understood through solvent-only simulations.
c.767A>GN256S
(3D Viewer)
Likely PathogenicC2Likely Pathogenic 1-10.640Likely Pathogenic0.950Likely PathogenicAmbiguous0.707Likely Pathogenic0.31Likely Benign0.20.36Likely Benign0.34Likely Benign0.48Likely Benign-4.33Deleterious0.997Probably Damaging0.970Probably Damaging5.87Benign0.02Affected3.3915112.7-27.03
c.1436G>AR479Q
(3D Viewer)
Likely BenignGAPUncertain 16-33438468-G-A74.34e-6-7.109In-Between0.259Likely BenignLikely Benign0.191Likely Benign0.54Ambiguous0.10.57Ambiguous0.56Ambiguous0.49Likely Benign-1.16Neutral1.000Probably Damaging0.991Probably Damaging3.42Benign0.31Tolerated3.3932111.0-28.06
c.1195G>AA399T
(3D Viewer)
Likely BenignC2Benign 1-5.236Likely Benign0.114Likely BenignLikely Benign0.272Likely Benign1.24Ambiguous0.10.91Ambiguous1.08Ambiguous0.49Likely Benign-0.40Neutral0.131Benign0.039Benign5.41Benign0.69Tolerated3.382610-2.530.03211.4-41.40.00.00.60.4XPotentially PathogenicThe methyl group of Ala399, located in an anti-parallel β sheet strand (res. Ala399-Ile411), is swapped for a hydroxyl-containing threonine. In the variant simulations, the hydroxyl group of Thr399 can form H-bonds with the backbone atoms of the residues in the membrane-facing loops (e.g., Gly382) in the C2 domain. Consequently, the ability of the Thr399 side chain to form H-bonds with the membrane-facing loops could adversely affect the dynamics and stability of the SynGAP-membrane association. However, since the effects on the dynamics of the membrane-facing loops can only be studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.662A>TE221V
(3D Viewer)
Likely PathogenicPHLikely Pathogenic 1-14.954Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.875Likely Pathogenic-0.66Ambiguous0.2-0.89Ambiguous-0.78Ambiguous0.49Likely Benign-5.54Deleterious0.596Possibly Damaging0.203Benign5.86Benign0.00Affected3.4113-2-27.7-29.98234.550.60.00.0-0.40.2XUncertainThe introduced residue Val221 is located on the outer surface of an anti-parallel β sheet strand (res. Cys219-Thr224). Unlike the carboxylate group of Glu221, Val221 cannot form hydrogen bonds with Thr223 or a salt bridge with the amino group of the Lys207 side chain. Despite this, the WT simulations containing Glu221 do not show significant differences compared to the variant simulations. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.775C>TR259W
(3D Viewer)
Likely PathogenicC2Uncertain 1-12.186Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.691Likely Pathogenic1.95Ambiguous0.80.51Ambiguous1.23Ambiguous0.51Ambiguous-7.35Deleterious1.000Probably Damaging0.993Probably Damaging5.76Benign0.00Affected3.39152-33.630.03254.040.00.20.20.20.4XXXPotentially PathogenicThe guanidinium group of Arg259, located at the beginning of an anti-parallel β sheet strand (res. Arg259-Arg272), forms salt bridges with the carboxylate groups of Asp684 at the end of an α helix (res. Ile683-Gln702, GAP domain) and Asp261 on the same β strand. The Arg259 side chain also frequently forms hydrogen bonds with the backbone carbonyl groups of Ser257, Asn256, and Asp255. In the variant simulations, the indole ring of the Trp259 side chain cannot form salt bridges or maintain hydrogen bonding with the carboxylate group of Asp684 or other nearby residues. Notably, the amino group of the Lys254 side chain maintains a salt bridge with Asp684 and Glu244 throughout the variant simulations, while it forms a cation-π bond with the indole ring of Trp259 in the variant. This salt bridge is not maintained in the WT simulations. Additionally, the partially or loosely α helical conformation of a lysine-containing loop (res. Lys251-Ser257), which extends to a nearby α helix (res. Met414-Asn426), could be stabilized due to the residue swap. Moreover, the bulky size of the Trp259 side chain requires nearby residues to adjust their positioning to accommodate the introduced residue, weakening the tertiary structure assembly between the C2, PH, and GAP domains. The residue swap potentially causes more severe effects during protein folding or for the SynGAP-membrane interaction than the solvent-only simulations imply.
c.958G>CV320L
(3D Viewer)
C2Uncertain 16-33437863-G-C63.72e-6-6.207Likely Benign0.362AmbiguousLikely Benign0.096Likely Benign-0.26Likely Benign0.21.33Ambiguous0.54Ambiguous0.51Ambiguous-1.02Neutral0.900Possibly Damaging0.373Benign1.78Pathogenic0.92Tolerated3.382321-0.414.03245.8-10.20.30.90.10.3XPotentially BenignThe isopropyl side chain of Val310, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Thr305-Asn315, res. Ala322-Asp330), hydrophobically packs with the side chains of nearby residues (e.g., Leu286, Val350, Pro318). The hydrophobic Leu320 side chain mostly forms the same interactions; hence, the residue swap does not seem to negatively affect the protein structure based on the variant simulations.
c.1285C>TR429W
(3D Viewer)
GAPConflicting 56-33438190-C-T654.03e-5-10.666Likely Pathogenic0.500AmbiguousLikely Benign0.282Likely Benign0.31Likely Benign0.1-0.13Likely Benign0.09Likely Benign0.52Ambiguous-3.19Deleterious1.000Probably Damaging0.990Probably Damaging3.41Benign0.03Affected3.38252-33.630.03252.345.50.00.00.20.1XPotentially PathogenicThe guanidinium group of Arg429, located in an α helix (res. Met414-Glu436), either forms a salt bridge with the carboxylate group of an acidic residue (Asp474, Asp467) or a H-bond with the hydroxyl group of Ser471 in an opposing α helix (res. Ala461-Phe476). In the variant simulations, the indole ring of the Trp429 side chain cannot form ionic interactions with the acidic residues. Although it forms a H-bond with Ser471, the bonding is not as strong as that of arginine. The residue swap could affect the tertiary structure assembly during folding; however, no large-scale negative effects were seen during the simulations.
c.1913A>GK638R
(3D Viewer)
Likely BenignGAPUncertain 1-2.700Likely Benign0.110Likely BenignLikely Benign0.216Likely Benign0.09Likely Benign0.1-0.04Likely Benign0.03Likely Benign0.53Ambiguous-2.55Deleterious0.649Possibly Damaging0.240Benign3.41Benign0.13Tolerated3.373123-0.628.01
c.1157G>AG386E
(3D Viewer)
C2Uncertain 16-33438062-G-A-9.286Likely Pathogenic0.686Likely PathogenicLikely Benign0.447Likely Benign3.69Destabilizing2.90.79Ambiguous2.24Destabilizing0.54Ambiguous-0.83Neutral0.860Possibly Damaging0.354Benign3.93Benign0.01Affected4.323-20-3.172.06
c.1729G>AA577T
(3D Viewer)
Likely BenignGAPBenign 16-33440781-G-A63.72e-6-5.311Likely Benign0.322Likely BenignLikely Benign0.427Likely Benign0.86Ambiguous0.10.54Ambiguous0.70Ambiguous0.54Ambiguous-1.47Neutral0.999Probably Damaging0.987Probably Damaging-1.31Pathogenic0.47Tolerated3.373410-2.530.03191.9-43.40.00.00.70.1XPotentially BenignAla577 is located near the end and outer surface of an α-helix (res. Arg563-Glu578), where its methyl group does not form any particular interactions in the WT simulations. In the variant simulations, the hydroxyl group of the Thr577 side chain hydrogen bonds with the backbone atoms of Arg573 and Lys574 within the same helix, which has the potential to weaken the stability of the secondary structure element. Regardless, the residue swap seems to be well tolerated based on the variant simulations.
c.2111G>AS704N
(3D Viewer)
Likely BenignGAPBenign/Likely benign 36-33441370-G-A271.67e-5-5.917Likely Benign0.421AmbiguousLikely Benign0.058Likely Benign0.48Likely Benign0.1-0.12Likely Benign0.18Likely Benign0.54Ambiguous-0.49Neutral0.771Possibly Damaging0.275Benign3.39Benign0.08Tolerated3.471011-2.727.03233.2-29.1-0.10.0-0.10.1XPotentially BenignSer704 is located at the end and outer surface of an α-helix (res. Thr704-Gly712), which is connected via a tight turn or loop to another α-helix (res. Asp684-Gln702). The hydroxyl side chain of Ser704 occasionally forms a hydrogen bond with the amide group of Ala707. However, in the variant simulations, the carboxamide side chain of Asn704 achieves more lasting and numerous hydrogen-bonding interactions with the residues at the helix end, such as Glu706, Ala707, and Leu708. Consequently, the residue swap could strengthen the α-helix secondary structure integrity at the helix end, which could have either positive or negative effects on its function.
c.2050G>CD684H
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.194Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.613Likely Pathogenic3.36Destabilizing1.02.95Destabilizing3.16Destabilizing0.55Ambiguous-6.98Deleterious1.000Probably Damaging0.972Probably Damaging3.36Benign0.00Affected3.4217-110.322.05
c.1702G>TV568L
(3D Viewer)
Likely PathogenicGAPUncertain 1-9.503Likely Pathogenic0.921Likely PathogenicAmbiguous0.651Likely Pathogenic-0.30Likely Benign0.30.57Ambiguous0.14Likely Benign0.56Ambiguous-2.69Deleterious0.511Possibly Damaging0.147Benign-1.23Pathogenic0.04Affected3.373512-0.414.03
c.1423C>TR475W
(3D Viewer)
Likely PathogenicGAPUncertain 16-33438455-C-T16.20e-7-13.235Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.725Likely Pathogenic1.44Ambiguous0.4-0.92Ambiguous0.26Likely Benign0.56Ambiguous-7.56Deleterious1.000Probably Damaging0.995Probably Damaging-1.45Pathogenic0.00Affected3.39282-33.630.03266.939.60.00.00.00.1XXXPotentially PathogenicIn the WT simulations, the guanidinium group of Arg475, located near the end of an α-helix (res. Ala461-Phe476), stacks with the phenyl ring of Phe476 and forms a salt bridge with Glu472. Additionally, Arg475 occasionally forms another salt bridge with the carboxylate group of Glu486 on the α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. Therefore, Arg475 potentially plays a key role in positioning the loop by interacting with Glu486, which is necessary for the positioning of the “arginine finger” (Arg485) and, ultimately, for RasGTPase activation.In the variant simulations, Trp475 moves and stacks with Arg479 on the proceeding α-α loop, disrupting the terminal end of the α-helix. Lastly, the potential effect of the residue swap on the SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1465C>TL489F
(3D Viewer)
Likely PathogenicGAPUncertain 26-33438497-C-T16.20e-7-12.066Likely Pathogenic0.965Likely PathogenicLikely Pathogenic0.724Likely Pathogenic1.72Ambiguous0.51.14Ambiguous1.43Ambiguous0.56Ambiguous-3.76Deleterious1.000Probably Damaging0.997Probably Damaging-1.51Pathogenic0.01Affected3.373520-1.034.02246.4-17.80.00.00.60.1XPotentially BenignThe iso-butyl side chain of Leu489, located in the α-helix (res. Leu489-Glu519) within an inter-helix space of four helices (res. Ala461-Phe476, res. Val441-Ser457, and res. Met414-Glu436), packs with hydrophobic residues (e.g., Cys432, Ala448, Lys444, Ala493, Val447, Met468) in the inter-helix space. In the variant simulations, the phenyl ring of the Phe489 side chain can also pack favorably in the hydrophobic region. However, due to the size difference, the aromatic side chain of Phe489 tends to reposition to escape the tight region to accommodate the larger side chain, stacking with Lys444. Although no apparent negative changes are observed during the variant simulation, the size difference between the swapped residues could affect the protein folding process.
c.1835A>CQ612P
(3D Viewer)
Likely PathogenicGAPUncertain 1-9.684Likely Pathogenic0.673Likely PathogenicLikely Benign0.671Likely Pathogenic-0.19Likely Benign0.33.06Destabilizing1.44Ambiguous0.56Ambiguous-5.84Deleterious1.000Probably Damaging1.000Probably Damaging-1.31Pathogenic0.19Tolerated0-11.9-31.01
c.2147G>AR716Q
(3D Viewer)
GAPConflicting 26-33441612-G-A42.48e-6-8.338Likely Pathogenic0.308Likely BenignLikely Benign0.210Likely Benign-0.01Likely Benign0.00.47Likely Benign0.23Likely Benign0.58Ambiguous-3.14Deleterious1.000Probably Damaging0.990Probably Damaging3.35Benign0.02Affected3.509111.0-28.06250.048.90.00.0-0.50.0XUncertainThe guanidinium group of Arg716, located on the outer surface of an α-helix (res. Leu714-Arg726), forms a salt bridge with the carboxylate group of Asp720. In the variant simulations, the carboxamide group of Gln716 also forms a hydrogen bond with the carboxylate group of Asp720, although this bond is weaker than the Arg716 salt bridge in the WT. Overall, no adverse effects on the protein structure are observed in the simulations. However, because the model ends abruptly at the C-terminus, no definite conclusions can be drawn based on the simulations.
c.892C>TP298S
(3D Viewer)
Likely BenignC2Benign 16-33437797-C-T53.10e-6-6.342Likely Benign0.144Likely BenignLikely Benign0.189Likely Benign1.38Ambiguous0.21.41Ambiguous1.40Ambiguous0.58Ambiguous-1.20Neutral0.991Probably Damaging0.898Possibly Damaging2.03Pathogenic0.85Tolerated3.3920-110.8-10.04
c.962G>AR321H
(3D Viewer)
C2Uncertain 16-33437867-G-A84.96e-6-8.751Likely Pathogenic0.136Likely BenignLikely Benign0.323Likely Benign0.48Likely Benign0.1-0.36Likely Benign0.06Likely Benign0.59Ambiguous-1.43Neutral1.000Probably Damaging0.998Probably Damaging1.92Pathogenic0.25Tolerated3.3823201.3-19.05218.586.91.10.00.30.0XPotentially BenignThe guanidinium group of Arg321, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Thr305-Asn315, res. Ala322-Asp330), faces outward without forming any stable interactions in the WT simulations. Similarly, in the variant simulations, the imidazole ring of His321 also points outward without making any stable intra-protein interactions. Thus, the residue swap does not seem to cause adverse effects on the protein structure based on the simulations. However, β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant.
c.1354G>TV452F
(3D Viewer)
Likely PathogenicGAPUncertain 1-14.769Likely Pathogenic0.975Likely PathogenicLikely Pathogenic0.511Likely Pathogenic9.21Destabilizing0.10.37Likely Benign4.79Destabilizing0.61Ambiguous-4.94Deleterious0.999Probably Damaging0.993Probably Damaging3.29Benign0.00Affected3.3734-1-1-1.448.04249.4-35.70.00.00.40.1XPotentially PathogenicThe iso-propyl side chain of Val452, located in the middle of an α helix (res. Val441-Ser457), packs against hydrophobic residues in the inter-helix space at the intersection of three α helices (e.g., Leu500, His453, Leu465). In the variant simulations, the larger side chain of Phe452 cannot pack against the opposing α helix (res. Leu489-Glu519) as efficiently as valine. Due to space restrictions, the phenol ring adjusts to make room by rotating slightly sideways in the inter-helix space. Besides this small and local shift, no large-scale effects on the protein structure are seen based on the simulations. However, the size difference between the swapped residues could affect the protein folding process.
c.694G>AA232T
(3D Viewer)
PHBenign 16-33435545-G-A16.20e-7-7.655In-Between0.874Likely PathogenicAmbiguous0.469Likely Benign0.47Likely Benign0.1-0.04Likely Benign0.22Likely Benign0.61Ambiguous-1.42Neutral0.608Possibly Damaging0.240Benign5.80Benign0.09Tolerated3.401410-2.530.03210.8-42.00.50.10.40.5XUncertainThe hydroxyl group of Thr232, located at the end of an anti-parallel β sheet strand (res. Thr228-Ala232), forms hydrogen bonds with nearby residues Glu217, Cys233, and Cys219 in the variant simulations. These hydrogen-bonding interactions at the β sheet surface contribute to the stability of the secondary structure element and prevent it from unfolding. The new hydrogen bond interactions may be more favorable for structural stability than the steric interactions of the methyl side chain of Ala with the side chains of Gln216 and Cys219 in the WT. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.1193C>TP398L
(3D Viewer)
C2Uncertain 16-33438098-C-T84.96e-6-7.518In-Between0.547AmbiguousLikely Benign0.599Likely Pathogenic1.48Ambiguous0.2-0.54Ambiguous0.47Likely Benign0.62Ambiguous-7.10Deleterious0.961Probably Damaging0.256Benign5.72Benign0.01Affected3.4016-3-35.416.04245.8-68.6-0.10.0-0.30.2XPotentially PathogenicPro398 is located in the Gly-rich Ω loop (res. Pro364-Pro398) between two anti-parallel β sheet strands (res. Thr359-Pro364 and res. Ala399-Ile411). The Ω loop is assumed to directly interact with the membrane, and it is observed to move arbitrarily throughout the WT solvent simulations. Although the residue swap does not influence the nearby secondary structure elements, proline is often found at the ends of β sheets due to its disfavored status during folding.Additionally, the Ω loop potentially plays a crucial role in the SynGAP-membrane complex association, stability, and dynamics. However, this aspect cannot be fully addressed through solvent simulations alone. Ω loops are known to play significant roles in protein functions that require flexibility, and thus hydrophobic residues like leucine are rarely tolerated. Although no negative structural effects are visualized in the variant’s simulations, Leu398 may exert drastic effects on the SynGAP-membrane complex dynamics and stability. Since the effects on the Gly-rich Ω loop dynamics can only be well studied through the SynGAP-membrane complex, no definite conclusions can be drawn.
c.1640G>AC547Y
(3D Viewer)
Likely PathogenicGAPPathogenic 1-15.871Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.874Likely Pathogenic8.53Destabilizing1.86.20Destabilizing7.37Destabilizing0.62Ambiguous-10.57Deleterious1.000Probably Damaging0.998Probably Damaging-1.33Pathogenic0.06Tolerated3.37350-2-3.860.04280.1-54.80.00.00.00.0XXXPotentially PathogenicCys547 is located in an α-helix (res. Ala533-Val560). The thiol side chain of Cys547 is situated in a hydrophobic inter-helix space, where it packs hydrophobically with other residues such as Ile626, Leu551, and Phe652. Additionally, the thiol side chain of Cys weakly hydrogen bonds with the carbonyl group of Leu543 in the same α-helix. In the variant simulations, the bulkier phenol ring of Tyr547, with its polar hydroxyl group, is less suited for the hydrophobic space. Consequently, it moves outside and forms a hydrogen bond with the carbonyl group of Phe652 in the neighboring α-helix (res. Glu666-Asp644). This causes the two helices to slightly separate, negatively affecting the secondary structure integrity of the latter helix. These negative structural effects could be more pronounced during protein folding and are likely to be undermined in the MD simulations.
c.667A>TT223S
(3D Viewer)
PHConflicting 26-33435518-A-T31.86e-6-7.714In-Between0.410AmbiguousLikely Benign0.535Likely Pathogenic0.26Likely Benign0.10.50Ambiguous0.38Likely Benign0.62Ambiguous-2.86Deleterious0.421Benign0.058Benign5.80Benign0.02Affected3.411311-0.1-14.03200.717.3-0.20.20.00.0XUncertainThe introduced residue Ser223 is located on the outer surface of an anti-parallel β sheet strand (res. Cys219-Thr224). Its hydroxyl group forms hydrogen bonds with nearby residues Thr228 and Lys207 in the variant simulations, similar to the hydroxyl group of Thr223 in the WT simulations. These hydrogen-bonding interactions at the β sheet surface contribute to the stability of the secondary structure element and may prevent it from unfolding. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.1635G>AM545I
(3D Viewer)
Likely PathogenicGAPUncertain 1-8.348Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.592Likely Pathogenic0.47Likely Benign0.10.14Likely Benign0.31Likely Benign0.63Ambiguous-3.61Deleterious0.935Possibly Damaging0.941Probably Damaging-1.27Pathogenic0.28Tolerated3.3735122.6-18.03
c.859G>CD287H
(3D Viewer)
Likely PathogenicC2Likely Pathogenic 1-14.518Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.589Likely Pathogenic0.48Likely Benign0.30.32Likely Benign0.40Likely Benign0.63Ambiguous-6.43Deleterious1.000Probably Damaging0.999Probably Damaging1.51Pathogenic0.00Affected3.38231-10.322.05235.63.80.11.20.10.1XXPotentially PathogenicThe carboxylate group of Asp287, located at the beginning of a β hairpin loop connecting two anti-parallel β sheet strands (res. Arg279-Leu286, res. Met289-Pro298), maintains a salt bridge with the guanidinium group of Arg324 in the β sheet during the WT simulations. In the variant simulations, the imidazole ring of the His287 side chain is unable to form a salt bridge with Arg324 or establish any other stable compensatory interactions, which could weaken the beta sandwich assembly of the C2 domain. This destabilization of the C2 domain could adversely affect the stability of the SynGAP-membrane association.
c.1888A>GI630V
(3D Viewer)
GAPBenign/Likely benign 46-33440940-A-G593.66e-5-7.264In-Between0.145Likely BenignLikely Benign0.143Likely Benign1.33Ambiguous0.00.94Ambiguous1.14Ambiguous0.64Ambiguous-0.38Neutral0.018Benign0.011Benign-1.37Pathogenic0.35Tolerated3.373443-0.3-14.03235.026.2-0.10.0-0.30.1XPotentially BenignThe sec-butyl side chain of Ile630, located in an α helix (res. Glu617-Asn635), packs with hydrophobic residues (e.g., Phe594, Leu633, Ile626, Ile602) in the hydrophobic inter-helix space between two α helices (res. Glu617-Asn635 and res. Glu582-Met603).In the variant simulations, the iso-propyl side chain of Val630, which shares a similar size and physicochemical properties with Ile630 in the WT, maintains similar interactions in the inter-helix space. Although no negative structural effects are observed during the simulations, the implications of the residue swap on the complex formation with the GTPase, due to its location, cannot be investigated using solvent-only simulations.
c.707C>TA236V
(3D Viewer)
PHBenign/Likely benign 26-33435558-C-T63.72e-6-8.752Likely Pathogenic0.267Likely BenignLikely Benign0.777Likely Pathogenic0.61Ambiguous0.21.08Ambiguous0.85Ambiguous0.64Ambiguous-3.55Deleterious0.981Probably Damaging0.446Benign5.79Benign0.03Affected3.4014002.428.05213.8-44.70.00.0-0.20.2XPotentially BenignThe methyl side chain of Ala236, located on an α helix (residues Ala236-Val250) facing an anti-parallel β sheet strand (residues Ile205-Val209), interacts hydrophobically with nearby residues such as Arg239 and Phe218. In the variant simulations, the isopropyl branched hydrocarbon side chain of Val236 maintains similar hydrophobic interactions as alanine in the WT, with an overall arrangement remarkably similar to Ala236. The residue swap does not affect the protein structure based on the simulations.
c.2014A>GT672A
(3D Viewer)
Likely BenignGAPBenign 16-33441273-A-G31.86e-6-6.524Likely Benign0.109Likely BenignLikely Benign0.046Likely Benign0.51Ambiguous0.31.15Ambiguous0.83Ambiguous0.65Ambiguous-3.20Deleterious0.006Benign0.002Benign3.44Benign0.12Tolerated3.4025102.5-30.03188.542.5-0.10.30.20.0XPotentially PathogenicThe hydroxyl group of Thr672, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop itself, such as Lys566, Glu666, and Asn669. In the variant simulations, Ala672 can only form a hydrogen bond with Lys566 via its backbone carbonyl group. Consequently, it cannot maintain the Lys566-Glu666 salt bridge through hydrogen bonding, leading to a significant disruption of the intricate and stable hydrogen-bond network between the loop and the helices.
c.970C>TR324W
(3D Viewer)
Likely PathogenicC2Uncertain 16-33437875-C-T21.24e-6-12.906Likely Pathogenic0.694Likely PathogenicLikely Benign0.481Likely Benign1.49Ambiguous0.30.56Ambiguous1.03Ambiguous0.66Ambiguous-3.12Deleterious1.000Probably Damaging0.998Probably Damaging1.82Pathogenic0.16Tolerated3.39222-33.630.03256.639.10.00.10.30.2XPotentially PathogenicThe guanidinium group of Arg324, located at the end of an anti-parallel β sheet strand (res. Ala322-Asp330), faces outward and frequently forms a salt bridge with the carboxylate group of the Asp288 side chain, which is part of a β strand end (res. Met289-Pro298). In the variant simulations, the indole ring of the Trp324 side chain cannot maintain a similar interaction with the negatively charged carboxylate side chain of Asp288, potentially compromising the folding of the anti-parallel β sheet assembly. However, the residue swap does not appear to negatively impact the protein structure or its integrity based on the simulations.
c.1370G>AS457NLikely PathogenicGAPUncertain 1-10.221Likely Pathogenic0.949Likely PathogenicAmbiguous0.241Likely Benign0.19Likely Benign0.0-0.22Likely Benign-0.02Likely Benign0.67Ambiguous-2.76Deleterious0.940Possibly Damaging0.843Possibly Damaging3.28Benign0.06Tolerated11-2.727.03
c.1741C>TR581W
(3D Viewer)
Likely PathogenicGAPUncertain 2-12.855Likely Pathogenic0.920Likely PathogenicAmbiguous0.678Likely Pathogenic1.32Ambiguous0.1-0.32Likely Benign0.50Ambiguous0.68Ambiguous-6.79Deleterious1.000Probably Damaging0.997Probably Damaging-1.37Pathogenic0.01Affected3.37342-33.630.03257.836.00.10.10.10.3XXPotentially PathogenicArg581 is located on a short α-α loop between two α helices (res. Arg563-Glu578 and res. Glu582-Ser604). In the WT simulations, the guanidinium group of Arg581 forms salt bridges with the carboxylate groups of Asp583 within the same helix, as well as with Glu478 and/or Glu480 in a slightly α-helical loop (res. Glu478-Thr488) preceding another α helix (res. Ala461-Phe476).In the variant simulations, the neutral indole ring of the Trp581 side chain cannot form any of these salt bridges. Instead, it packs hydrophobically against Met477 and Ile587 without forming any direct hydrogen bonds. The tendency of the loop (res. Asp477-Thr488) to acquire an α-helical structure seems to marginally increase, potentially due to Trp581's inability to coordinate stable hydrogen bonds with the loop residues (e.g., Glu478-Arg581 salt bridge). Additionally, the residue swap could weaken the tertiary structure assembly and negatively affect the overall protein folding process.
c.1483G>AE495K
(3D Viewer)
Likely PathogenicGAPUncertain 1-11.478Likely Pathogenic0.986Likely PathogenicLikely Pathogenic0.869Likely Pathogenic0.15Likely Benign0.20.66Ambiguous0.41Likely Benign0.70Ambiguous-3.91Deleterious0.999Probably Damaging0.994Probably Damaging-1.29Pathogenic0.01Affected3.373510-0.4-0.94
c.1651C>AL551M
(3D Viewer)
GAPUncertain 16-33438894-C-A74.34e-6-9.937Likely Pathogenic0.480AmbiguousLikely Benign0.544Likely Pathogenic-0.07Likely Benign0.10.13Likely Benign0.03Likely Benign0.71Ambiguous-0.56Neutral1.000Probably Damaging1.000Probably Damaging-1.48Pathogenic0.06Tolerated3.373542-1.918.03246.5-18.60.00.00.30.0XPotentially BenignL551 is located on an α-helix (res. Ala533-Val560). The iso-butyl side chain of Leu551 hydrophobically packs with nearby hydrophobic residues such as Cys547, Phe652, Leu633, and Ile630 in the inter-helix space. In the variant simulations, the thioether side chain of Met551 can maintain similar hydrophobic interactions as Leu551 in the WT, thus causing no negative effect on the protein structure during the simulations.
c.1768A>GS590G
(3D Viewer)
Likely PathogenicGAPConflicting 26-33440820-A-G148.67e-6-14.277Likely Pathogenic0.574Likely PathogenicLikely Benign0.379Likely Benign0.67Ambiguous0.11.28Ambiguous0.98Ambiguous0.71Ambiguous-3.92Deleterious1.000Probably Damaging0.922Probably Damaging3.42Benign0.06Tolerated3.3735100.4-30.03186.749.40.00.00.10.0XPotentially PathogenicIn the WT simulations, the hydroxyl group of Ser590, located on an α helix (res. Glu582-Met603), forms hydrogen bonds with the backbone carbonyl of Ala634 and/or the carboxamide group of the Asn635 side chain at the end of the opposing α helix (res. Thr619-Ala634).The residue swap could weaken the integrity of the α helix, as glycine is known as an “α helix breaker.” However, no discernible difference was observed between the WT and variant simulations in this regard. Importantly, Gly590 cannot form hydrogen bonds with the opposing helix in the same way that serine can, which could weaken the tertiary structure assembly between the two helices.
c.662A>GE221G
(3D Viewer)
Likely PathogenicPHUncertain 1-12.221Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.863Likely Pathogenic1.40Ambiguous0.11.74Ambiguous1.57Ambiguous0.71Ambiguous-5.56Deleterious0.596Possibly Damaging0.201Benign5.79Benign0.00Affected0-23.1-72.06
c.1004G>AR335H
(3D Viewer)
Likely PathogenicC2Uncertain 16-33437909-G-A21.24e-6-12.521Likely Pathogenic0.831Likely PathogenicAmbiguous0.132Likely Benign0.58Ambiguous0.10.22Likely Benign0.40Likely Benign0.72Ambiguous-3.02Deleterious1.000Probably Damaging0.998Probably Damaging1.70Pathogenic0.03Affected3.3822201.3-19.05242.482.1-2.40.6-0.10.1UncertainThe guanidinium group of Arg335, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Ala322-Asp330, res. Gly341-Pro349), faces the post-synaptic inner membrane surface. In the WT simulations, the Arg335 side chain dynamically forms salt bridges with the carboxylate groups of Asp322, Asp338, and Asp616. In contrast, the imidazole ring of His335, which is not double protonated and thus not positively charged in the variant simulations, continues to move dynamically without forming any lasting or strong interactions. Importantly, the positively charged arginine residues of the C2 domain are ideal membrane anchors for ensuring SynGAP-membrane association. However, this phenomenon cannot be addressed using solvent-only simulations.
c.1222A>GT408AC2Uncertain 1-8.304Likely Pathogenic0.114Likely BenignLikely Benign0.118Likely Benign0.37Likely Benign0.6-0.06Likely Benign0.16Likely Benign0.72Ambiguous-3.07Deleterious0.540Possibly Damaging0.131Benign4.16Benign0.14Tolerated102.5-30.03
c.1678G>AV560M
(3D Viewer)
GAPUncertain 26-33440730-G-A159.50e-6-9.598Likely Pathogenic0.517AmbiguousLikely Benign0.520Likely Pathogenic-0.33Likely Benign0.10.88Ambiguous0.28Likely Benign0.72Ambiguous-2.42Neutral0.999Probably Damaging0.863Possibly Damaging-1.25Pathogenic0.14Tolerated3.373521-2.332.06234.9-52.60.00.0-0.10.1XPotentially BenignVal560 is located on the surface at the end of an α-helix (res. Ala533-Val560). The iso-propyl group of Val560 favorably packs against Asp508 of the opposing α-helix (res. Gln503-Glu519). However, in the variant simulations, the bulkier thioether side chain of Met560 does not form equally favorable inter-helix interactions. Regardless, no negative structural effects are observed during the simulations.
c.2015C>AT672K
(3D Viewer)
Likely PathogenicGAPUncertain 1-12.192Likely Pathogenic0.698Likely PathogenicLikely Benign0.065Likely Benign0.20Likely Benign0.51.21Ambiguous0.71Ambiguous0.72Ambiguous-4.31Deleterious0.745Possibly Damaging0.051Benign3.40Benign0.07Tolerated3.40250-1-3.227.07195.17.00.40.70.40.1XXPotentially PathogenicThe hydroxyl group of Thr672, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is involved in a highly coordinated hydrogen-bonding network between residues from two α-helices (res. Ser641-Glu666 and res. Arg563-Glu578) and from the α-α loop itself, such as Lys566, Glu666, and Asn669. In the variant simulations, Lys672 can only form a hydrogen bond with the amino group of the Lys566 side chain via its backbone carbonyl group. Consequently, it cannot maintain the Lys566-Glu666 salt bridge through hydrogen bonding. However, the amino group of Lys periodically forms a salt bridge with the carboxylate group of Glu666, which prevents a drastic disruption of the hydrogen-bond network that keeps the loop close to the helices.
c.1723C>TR575C
(3D Viewer)
Likely PathogenicGAPConflicting 36-33440775-C-T231.43e-5-11.179Likely Pathogenic0.630Likely PathogenicLikely Benign0.715Likely Pathogenic1.39Ambiguous0.20.50Ambiguous0.95Ambiguous0.73Ambiguous-5.43Deleterious1.000Probably Damaging1.000Probably Damaging-1.30Pathogenic0.02Affected3.3735-4-37.0-53.05227.799.20.00.00.00.1XPotentially PathogenicThe guanidinium group of Arg575, located in an α-helix (res. Arg563-Glu578), forms salt bridges with the carboxylate groups of Asp463 and Asp467, and it also hydrogen bonds with the hydroxyl group of Ser466 on an opposing α-helix (res. Ala461-Phe476) in the WT simulations. In the variant simulations, the thiol group of the Cys575 side chain, which is neither positively charged nor particularly hydrophilic, packs against the hydrophobic Met470 on an opposing α-helix (res. Ala461-Arg475). Additionally, although the thiol group is not an effective hydrogen bonder, the Cys575 side chain rotates to hydrogen bond with the backbone carbonyl group of Ser571 in the same α-helix, which could theoretically lower the helix integrity. Overall, the residue swap has the potential to substantially affect the tertiary structure assembly during the protein folding process.
c.667A>GT223A
(3D Viewer)
PHUncertain 16-33435518-A-G31.86e-6-7.076In-Between0.316Likely BenignLikely Benign0.574Likely Pathogenic0.30Likely Benign0.10.77Ambiguous0.54Ambiguous0.74Ambiguous-3.36Deleterious0.231Benign0.058Benign5.74Benign0.09Tolerated3.4113102.5-30.03186.444.00.00.00.00.0XXUncertainThe introduced residue Ala223 is located on the outer surface of an anti-parallel β sheet strand (res. Cys219-Thr224). Unlike the hydroxyl group of the Thr223 side chain in the WT protein, the methyl side chain of Ala223 cannot form hydrogen bonds with nearby residues Thr228 and Lys207. Without these hydrogen-bonding interactions at the β sheet surface, the secondary structure element becomes unstable and partially unfolds in the variant simulations. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.1428C>GF476L
(3D Viewer)
GAPUncertain 26-33438460-C-G42.48e-6-10.109Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.180Likely Benign1.00Ambiguous0.11.04Ambiguous1.02Ambiguous0.75Ambiguous-1.10Neutral0.997Probably Damaging0.978Probably Damaging3.53Benign0.60Tolerated3.4022201.0-34.02235.916.10.00.1-0.20.0XPotentially BenignIn the WT simulations, the phenyl ring of Phe476, located at the end of an α-helix (res. Ala461-Phe476), packs with the hydrophobic side chains of Leu482 and Ile483. Additionally, Phe476 stacks with the Arg475 side chain on the preceding α-α loop connecting the two α-helices (res. Ala461-Phe476 and res. Leu489-Glu519) near the GAP-Ras interface.In the variant simulations, Leu476 can maintain hydrophobic packing with neighboring residues, although not as efficiently as the phenylalanine in the WT system. The absence of Phe476/Arg475 stacking weakens the integrity of the α-helix end in the variant simulations. Nonetheless, no large-scale adverse effects are observed in the simulations. Lastly, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.937G>AE313K
(3D Viewer)
Likely PathogenicC2Likely Benign 1-12.902Likely Pathogenic0.959Likely PathogenicLikely Pathogenic0.575Likely Pathogenic0.64Ambiguous0.61.40Ambiguous1.02Ambiguous0.75Ambiguous-3.31Deleterious1.000Probably Damaging0.995Probably Damaging1.90Pathogenic0.02Affected01-0.4-0.94
c.1042G>AV348M
(3D Viewer)
C2Uncertain 1-7.076In-Between0.546AmbiguousLikely Benign0.191Likely Benign-1.19Ambiguous0.10.72Ambiguous-0.24Likely Benign0.76Ambiguous-1.62Neutral0.966Probably Damaging0.564Possibly Damaging1.58Pathogenic0.03Affected3.372521-2.332.06253.8-47.4-0.30.10.20.1XPotentially BenignThe iso-propyl side chain of Val348, located in an anti-parallel β sheet strand (res. Gly341-Pro349), packs against multiple hydrophobic C2 domain residues (e.g., Leu353, Leu323, Leu402). In the variant simulations, the thioether side chain of Met348 can form similar interactions as valine due to its comparable hydrophobic profile. In fact, the thioether group of methionine can even stack favorably with the phenol ring of Tyr363 in the anti-parallel β sheet strand (res. Ala399-Ile411). Overall, the residue swap does not appear to cause negative effects on the protein structure based on the simulations.
c.1622C>GA541G
(3D Viewer)
GAPUncertain 16-33438865-C-G21.24e-6-7.233In-Between0.341AmbiguousLikely Benign0.421Likely Benign0.67Ambiguous0.00.94Ambiguous0.81Ambiguous0.76Ambiguous-1.48Neutral0.999Probably Damaging0.995Probably Damaging-1.31Pathogenic0.57Tolerated3.373510-2.2-14.03170.123.60.00.00.00.0XPotentially PathogenicAla541 is located on the outer surface of an α-helix (res. Ala533-Val560). The methyl group of Ala541 is on the surface and does not form any interactions. Glycine, known as an “α-helix breaker,” weakens the integrity of the helix. Indeed, in the variant simulations, the hydrogen bond formation between Gly541 and the backbone carbonyl of Ala537 is disrupted.
c.2047A>GI683V
(3D Viewer)
Likely BenignGAPUncertain 16-33441306-A-G21.24e-6-7.588In-Between0.138Likely BenignLikely Benign0.112Likely Benign0.90Ambiguous0.00.60Ambiguous0.75Ambiguous0.76Ambiguous-0.78Neutral0.538Possibly Damaging0.080Benign3.35Benign0.14Tolerated3.421743-0.3-14.03215.629.10.00.0-0.70.1XPotentially BenignThe sec-butyl side chain of Ile683, located in an entangled α-α loop connecting the two α-helices (res. Ser641-Glu666 and res. Leu685-Val699), is sterically packed against His453 and Glu688. In the variant simulations, the iso-propyl side chain of Val683 has similar size and physicochemical properties as Ile630 in the WT, and thus, it is able to maintain similar interactions in the inter-helix space. Consequently, no negative structural effects are observed during the simulations due to the residue swap.
c.895C>TR299C
(3D Viewer)
Likely PathogenicC2Conflicting 26-33437800-C-T31.86e-6-6.326Likely Benign0.572Likely PathogenicLikely Benign0.344Likely Benign1.85Ambiguous0.40.61Ambiguous1.23Ambiguous0.76Ambiguous-3.54Deleterious1.000Probably Damaging0.998Probably Damaging1.65Pathogenic0.06Tolerated3.3919-4-37.0-53.05210.791.30.10.00.00.2XXPotentially PathogenicThe guanidinium group of Arg299, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Met289-Pro298, res. Thr305-Asn315), forms hydrogen bonds that stabilize the tight turn. In the WT simulations, the Arg299 side chain hydrogen bonds with the loop backbone carbonyl groups (e.g., Ser302, Thr305, Leu274, Gly303), the hydroxyl group of Ser300, and even forms a salt bridge with the carboxylate group of Asp304.In the variant simulations, the thiol group of the Cys299 side chain is unable to form any of these well-coordinated or strong interactions, which could affect the initial formation of the secondary hairpin loop during folding. β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. Moreover, the positively charged Arg299 side chain faces the polar head group region of the inner leaflet membrane and could directly anchor the C2 domain to the membrane. In short, the residue swap could negatively affect both protein folding and the stability of the SynGAP-membrane association.
c.913A>GT305A
(3D Viewer)
Likely BenignC2Conflicting 26-33437818-A-G138.05e-6-4.307Likely Benign0.078Likely BenignLikely Benign0.144Likely Benign1.30Ambiguous0.61.55Ambiguous1.43Ambiguous0.77Ambiguous-2.10Neutral0.939Possibly Damaging0.645Possibly Damaging1.76Pathogenic0.12Tolerated3.4020102.5-30.03177.943.5-0.20.10.40.0UncertainThe hydroxyl group of Thr305, located at the beginning of an anti-parallel β strand (res. Thr305-Asn315), hydrogen bonds with the carboxylate groups of Glu270 and Asp304 in the anti-parallel β strand and the adjacent β hairpin loop, respectively. In the variant simulations, the methyl group of the Ala305 side chain cannot hydrogen bond with either of the acidic residues, which could weaken the integrity of the tertiary structure and the β hairpin loop. Indeed, the guanidinium group of Arg299 does not acquire its central hairpin loop position due to the residue swap.β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. Due to its location near the membrane surface, the residue swap could also affect the C2 loop dynamics and SynGAP-membrane association. However, this is beyond the scope of the solvent-only simulations to unravel.
c.1484A>GE495G
(3D Viewer)
Likely PathogenicGAPUncertain 16-33438516-A-G16.20e-7-9.400Likely Pathogenic0.923Likely PathogenicAmbiguous0.867Likely Pathogenic1.21Ambiguous0.02.06Destabilizing1.64Ambiguous0.78Ambiguous-6.70Deleterious1.000Probably Damaging0.999Probably Damaging-1.46Pathogenic0.02Affected3.3735-203.1-72.06
c.1658A>CK553T
(3D Viewer)
Likely PathogenicGAPUncertain 1-15.328Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.761Likely Pathogenic1.06Ambiguous0.20.48Likely Benign0.77Ambiguous0.79Ambiguous-5.77Deleterious1.000Probably Damaging1.000Probably Damaging-1.34Pathogenic0.14Tolerated3.37350-13.2-27.07218.2-10.70.00.0-0.20.5XPotentially PathogenicLys533 is located on an α-helix (res. Ala533-Val560). In the WT simulations, Lys533 packs against Phe513, and its amino side chain occasionally forms an ionic interaction with the carboxylate group of Glu512 from an opposing α-helix (res. Gln503-Tyr518). In the variant simulations, Thr533 is unable to reproduce these interactions, potentially weakening the integrity of the tertiary structure. Additionally, Thr533 forms a hydrogen bond with the backbone carbonyl group of Leu549 in the same helix, which could potentially weaken the secondary structure. Regardless, the residue swap does not cause significant structural effects based on the simulations.
c.1718G>TR573L
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-13.120Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.833Likely Pathogenic1.30Ambiguous0.61.11Ambiguous1.21Ambiguous0.80Ambiguous-5.74Deleterious1.000Probably Damaging1.000Probably Damaging-1.41Pathogenic0.01Affected3.3735-3-28.3-43.03237.460.70.00.0-0.70.3XXPotentially PathogenicThe guanidinium group of Arg573, located in an α-helix (res. Arg563-Glu578), forms a salt bridge with the carboxylate groups of Glu582 and/or Asp586 from a nearby α-helix (res. Glu582-Met603) in the WT simulations. Additionally, the Arg573 side chain stacks planarly with the aromatic phenol ring of Tyr665 and hydrogen bonds with the hydroxyl group of Ser668 from another α-helix (res. Ser641-Ser668). In the variant simulations, the aliphatic iso-butyl group of the Leu573 side chain fails to establish any of these interactions, which, in turn, lowers the integrity of the opposing α-helix end (res. Glu582-Met603). Overall, the residue swap has the potential to substantially affect the tertiary structure assembly during the protein folding process.10.1016/j.ajhg.2020.11.011
c.835C>TR279W
(3D Viewer)
Likely PathogenicC2Uncertain 1-11.417Likely Pathogenic0.942Likely PathogenicAmbiguous0.485Likely Benign2.00Destabilizing0.81.47Ambiguous1.74Ambiguous0.80Ambiguous-6.29Deleterious1.000Probably Damaging0.998Probably Damaging1.88Pathogenic0.00Affected3.39182-33.630.03270.038.30.10.00.30.0UncertainThe guanidinium group of Arg279, located at the beginning of an anti-parallel β sheet strand (res. Arg279-Leu286), can form hydrogen bond with the backbone carbonyl groups of nearby loop residues (e.g., Ser296, Ser331, and As332) and form salt bridges with the carboxylate groups of Asp330 and Asp332. In the WT simulations, Arg279 sporadically forms a salt bridge even with the carboxylate group of Glu613, loosely connecting the C2 domain and GAP domain. Meanwhile, the indole ring of the Trp279 side chain is unable to hydrogen bond with the loop residues in the variant simulations. The lack of hydrogen bond or salt bridge formation with the loop residues could be significant, as Arg279 and the loops face the polar head group region of the membrane. Thus, although Trp279 could interact with the membrane surface as a “lipid anchor,” any changes to the wider loop dynamics could still adversely affect the formation of a stable SynGAP-membrane association. However, no definite conclusions on the effect of the residue swap on the SynGAP-membrane association can be drawn from solvent-only simulations.
c.1436G>CR479P
(3D Viewer)
Likely PathogenicGAPUncertain 1-11.795Likely Pathogenic0.938Likely PathogenicAmbiguous0.277Likely Benign2.86Destabilizing0.23.88Destabilizing3.37Destabilizing0.81Ambiguous-3.52Deleterious1.000Probably Damaging1.000Probably Damaging3.41Benign0.18Tolerated0-22.9-59.07
c.1802C>TA601V
(3D Viewer)
Likely PathogenicGAPUncertain 1-10.447Likely Pathogenic0.853Likely PathogenicAmbiguous0.535Likely Pathogenic1.64Ambiguous0.10.35Likely Benign1.00Ambiguous0.81Ambiguous-3.98Deleterious1.000Probably Damaging0.989Probably Damaging2.74Benign0.03Affected3.3735002.428.05228.5-45.50.00.00.40.5XPotentially BenignThe methyl side chain of Ala601, located on an α helix (res. Glu582-Met603), packs hydrophobically against other hydrophobic residues in the inter-helix space (e.g., Phe597, Leu598, Leu506, Phe608).In the variant simulations, Val601, which has similar size and physicochemical properties to alanine, resides in the inter-helix hydrophobic space in a similar manner to Ala601 in the WT, causing no apparent negative effect on the protein structure. However, the effect of the residue swap on the SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1367A>CQ456P
(3D Viewer)
Likely PathogenicGAPUncertain 1-15.250Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.469Likely Benign3.68Destabilizing0.28.43Destabilizing6.06Destabilizing0.82Ambiguous-5.66Deleterious1.000Probably Damaging0.999Probably Damaging3.34Benign0.07Tolerated3.3734-101.9-31.01
c.1453C>AR485S
(3D Viewer)
Likely PathogenicGAPUncertain 1-15.603Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.609Likely Pathogenic0.40Likely Benign0.11.07Ambiguous0.74Ambiguous0.82Ambiguous-5.97Deleterious1.000Probably Damaging1.000Probably Damaging1.93Pathogenic0.00Affected0-13.7-69.11
c.1306G>AE436K
(3D Viewer)
Likely PathogenicGAPUncertain 1-13.869Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.829Likely Pathogenic0.56Ambiguous0.12.86Destabilizing1.71Ambiguous0.82Ambiguous-3.77Deleterious0.994Probably Damaging0.951Probably Damaging4.71Benign0.02Affected3.372901-0.4-0.94186.839.80.00.0-0.20.0XXXPotentially PathogenicThe carboxylate group of Glu436, located on the α helix (res. Met414-Glu436), forms a salt bridge with the amino group of the Lys444 side chain on an opposing α helix (res. Val441-Ser457). The backbone carbonyl of Glu436 also H-bonds with the Lys444 side chain, which helps keep the ends of the two α helices tightly connected. In contrast, in the variant simulations, the salt bridge formation with Lys444 is not possible. Instead, the repelled Lys436 side chain rotates outward, causing a change in the α helix backbone H-bonding: the amide group of Lys444 H-bonds with the carbonyl of Ala433 instead of the carbonyl of Cys432.

Found 757 rows. Show 200 rows per page. Page 3/4 |